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ABSTRACT 
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Department Chair of Biomedical Engineering 
 
 
 
Valvular heart disease (VHD) continues to have significant effects on many people’s lives, with 
numbers expected to grow tremendously over the next few years. Individuals suffering from 
severe valvular heart disease usually require a heart valve transplant in order to restore the native 
valve’s vital unidirectional flow regulation. Therefore, artificial heart valve (AHV) research is of 
very high importance. Previous research studies have provided substantial input in the realm of 
AHV design relative to durability, thrombotic and hemolytic potential, and overall functionality.  
However, modifications continue to be warranted due to limitations in the accuracy and time 
efficiency of the in vitro physiological flow replication process.  The objective of this 
investigation is to develop and analyze a method of AHV performance evaluation using a novel 
 
xi 
 
test chamber within an automated mock circulatory loop. The constructed mock loop was 
designed to maintain consistency of current industrial and academic research systems while 
providing innovative loop component control that allows for run-time changes and performance 
screening to various physiological conditions. Pressure sensors, ultrasonic flow meter, process 
controls and mechanical feedback sensors are managed via Labview in order to provide 
sufficient real-time performance analysis during system operation. In addition, a unique 
mechanical heart valve (MHV) test chamber was constructed to incorporate the test AHV in the 
mock loop flow path. This research exposes a test tilting disk MHV to a series of 12 heart rate 
and stroke volume combinations so as to evaluate the system’s effectiveness in pathological 
condition replication with respect to AHV design research. A Particle Image Velocimetry (PIV) 
system was utilized to illuminate particles in the flow field and obtain representative vector plots. 
Results of this study validate the combined experimental test chamber and automated mock 
circulatory loop as a viable MHV performance evaluation system by using real-time pressure and 
flow data to analyze system fluid dynamics at the MHV test site. Consequently, the use of this 
arrangement in MHV performance analysis greatly improves upon time restraints and accuracy 
concerns associated with currently used manually controlled setups. 
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1   INTRODUCTION 
 
1.1 Motivation and Significance 
Nearly 4.9 million Americans presently suffer from heart failure with over 500,000 new 
patients diagnosed each year [1]. Consequently, cardiovascular heart disease (CHD) is the 
leading cause of death in the United States, fatally affecting approximately one person every 34 
seconds [2]. While these statistics alone are reason for alarm, concern is heightened by evidence 
of similar trends worldwide. Therefore, as the number of people suffering from CHD continues 
to grow, so does the significance of research focused on cardiological deficiencies. One 
particular group of ailments, known as valvular heart disease (VHD), provide the impetus for this 
research and support the broader theme of finding novel solutions to cardiovascular disorder 
prevention and treatment. 
VHD affects more than 100 million people worldwide and accounts for 10% to 20% of 
all cardiac surgical procedures in the United States [3]. In addition, there are currently over 
290,000 surgical heart valve procedures conducted globally each year [4] with, roughly, one-
third of those being in North America [5]. This global total is expected to exceed 850,000 by the 
year 2050 [4], which denotes an annual percentage rate increase of 10-12%. As a direct result of 
the realities associated with these growth estimates, the prominence of heart valve exploration 
will progressively increase and, thus, provide an ever expanding contribution to society. 
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1.2 Function and Anatomy 
Heart valves control the unidirectional blood flow through the heart and, consequently, 
can have major effects on the overall efficiency of the entire cardiovascular system. They are 
facilitated via the formation of pressure gradients during each heart cycle which cause them to 
open and close as appropriately intended. 
There are four major valves in the human heart, excluding the coronary sinus and inferior 
vena cava valves. The tricuspid and bicuspid valves are the atrioventricular (AV) valves that lie 
between the respective atria and ventricles. The pulmonary and aortic valves are classified as 
semilunar (SL) valves and are located between the ventricles and exit arteries. Each side of the 
heart, right and left, contains two valves, one AV and one SL. 
1.2.1 Right Side of the Heart 
 The right side of the heart transports CO2 rich 
blood through the pulmonary cycle for oxygenation. The 
right atrium serves as the collection container for 
deoxygenated blood from the superior and inferior vena 
cava after it successfully undergoes systemic circulation 
through the body. Following blood return into the right 
atrium, blood moves into the right ventricle.  During 
systole, the right ventricle pumps blood through the 
pulmonary arteries and down to the lungs for CO2-O2 gas exchange via diffusion. The right heart 
contains the tricuspid AV valve (controls flow from right atrium to right ventricle) and the 
 
Figure1.1. [6] Right heart anatomy. 
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pulmonary SL valve (controls flow from the right ventricle into the pulmonary arteries). Figure 
1.1 depicts blood flow through the right heart. 
The normal tricuspid valve possesses three leaflets connected to three papillary muscles 
by chordae tendineae located in the right ventricle. The papillary muscles and chordae tendineae, 
subvalvular apparatus, do not affect 
valve function and primarily help hold 
the tricuspid valve in place using 
tension to provide stability. The 
tension also stops prolapse of the 
leaflets into the atrium, maintaining a 
tight seal. The tricuspid valve opens 
when the pressure of the right atrium 
surpasses the pressure in the right 
ventricle. This occurs during atrial 
contraction, ventricular diastole. At the beginning of right ventricle contraction, ventricular 
systole, blood attempts to flow back into the atrium. It is this flow, in conjunction with 
intraventricular pressure, which pushes against the valvular flaps causing the triscupid valve to 
close. 
The pulmonary valve has three cusps. It opens during ventricular systole when right 
ventricle pressure exceeds pulmonary artery pressure. Similarly, pulmonary valve closure occurs 
at the end of the systolic cycle when right ventricular pressure quickly drops, allowing pressure 
 
Figure 1.2. [7] Tricuspid (Red) and Pulmonary (Yellow) 
valve orientation. 
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in the pulmonary artery to once again become the larger of the two. Figure 1.2 illustrates 
pulmonary and tricuspid valve orientation, relative to the right heart chambers. 
1.2.2 Left Side of the Heart 
 The left side of the heart is the pumping mechanism for systemic circulation. It drives 
oxygenated pulmonic blood through the aorta and out to 
the tissues, muscles, and end organs where it undergoes 
O2-CO2 gas exchange. Blood exiting pulmonary 
circulation fills the left atrium, which then passes on to the 
left ventricle and, finally, out the aorta. The left heart 
encloses the bicuspid AV valve (controls flow from left 
atrium to left ventricle) and the aortic SL valve (controls 
flow from the left ventricle into the aorta). Figure 1.3 
navigates blood flow through the left heart. 
 The bicuspid valve (commonly known as the mitral valve) has two leaflets and typically 
occupies an area of 4-6 cm2.  The valve orifice is surrounded by a ring of fibrous tissue called an 
annulus. Like the tricuspid valve of the right heart, the mitral valve leaflets are attached to 
papillary muscles by chordae tendineae in the left ventricle. The mitral valve opens due to 
increased pressure from the left atrium as it fills with blood, which causes pressure increases 
above that of the left ventricle and allows blood to flow through the valve. The initial surge of 
blood occurs during early left ventricular diastole and accounts for 70-80% of the total filling of 
the ventricle (called early rapid filling). The other 20% of complete left ventricular volume 
 
Figure1.3. [6] Left heart anatomy. 
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comes from atrial contraction (atrial systole), which drives the remaining blood out of the left 
atrium. Valve closure ensues at the end of atrial contraction to prevent blood backflow. 
 The normal aortic valve contains three cusps, resembling the pulmonary valve. During 
ventricular systole, pressure rises in the left ventricle. When the pressure in the left ventricle rises 
above the pressure in the aorta, the aortic valve opens, allowing blood to exit the left ventricle 
into the aorta. Once ventricular systole 
ends, pressure in the left ventricle rapidly 
drops. The decrease in left ventricular 
pressure enables the force of the aortic 
pressure to close the aortic valve. Figure 
1.4 illustrates aortic and mitral valve 
orientation, relative to the left heart 
chambers. 
Identical to the right side, the lower 
ventricle on the left side of the heart is thicker and stronger than the upper atrium. However, the 
muscle wall surrounding the left ventricle is more bulky than the right ventricle, which makes the 
left ventricle more physically powerful. This difference allows the left side of the heart to 
provide a greater amount of force to successfully push the heavier, nutrient-rich blood through 
the longer systemic circulation. Using the general formula: WORK = FORCE X 
DISPLACEMENT, the greater force and longer distance of blood travel produced by the left side 
of the heart implicates a superior workload. Due to this massive difference in workload between 
the two sides, the left heart components are subjected to more strenuous circumstances than 
 
Figure 1.4. [7] Mitral (Green) and Aortic (Blue) 
valve orientation. 
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those of the right. As a result, left heart valves have an increased potential for failure. Thus, the 
majority of the previously noted 290,000 global surgical heart valve procedures [4] attempt to 
correct mitral and aortic valve complications on the left side of the heart. 
 
1.3 Pathologies and Diagnoses of Left Heart Valve Disease 
In cases of heart valve disease, problems arise when normal regulatory functionality of 
the valve is disrupted, leading to disturbances in blood flow [2, 8]. The primary diagnoses of 
heart valve disease include the incidence of stenosis, regurgitation, or a combination of the two. 
Stenosis occurs when the valve fails to open completely and fails to transfer the standard amount 
of blood through the opening. Regurgitation is the leakage of blood back through the valve in the 
reverse direction due to improper prevention of backflow. Both diagnoses have the potential to 
instigate additional cardiovascular complications, including failure and/or blood seepage into the 
lung. 
1.3.1 Mitral Valve Heart Disease 
1.3.1.1 Mitral Stenosis 
 Mitral stenosis is characterized by the narrowing of the mitral valve orifice within the 
heart. When the mitral valve area shrinks below the normal 4-6 cm2, specifically below 2 cm2, 
blood flow into the left ventricle is blocked, creating an abnormal pressure gradient increase 
across the mitral valve. This gradient is multiplied as the heart rate or cardiac output rises, which 
also raises the necessary amount of time needed to completely fill the left ventricle with blood. 
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As the heart rate increases, ventricular diastole decreases along with the amount of time needed 
for the ventricle to fill (diastolic filling period).  Therefore, once the heart rate reaches a certain 
threshold, the diastolic filling period is insufficient to fill the ventricle with blood and pressure 
builds up in the left atrium, leading to pulmonary congestion. Severe mitral stenosis occurs when 
the orifice is less than 1 cm2 and is often characterized by a pressure gradient across the mitral 
valve of more than 10 mmHg [9]. Meaning a pressure gradient of 20 mmHg, coupled with a 
normal left ventricular diastolic pressure of about 5 mmHg, results in a left atrial pressure of 
about 25 mmHg. Atrial pressures of this caliber lead to a variety of other complications including 
pulmonary hypertension, pulmonary edema, and atrial fibrillation [3, 9]. Furthermore, the 
accelerated heart rate joined with the shortened diastolic time produces a decreased cardiac 
output, often resulting in sudden congestive heart failure. 
1.3.1.2 Mitral Regurgitation 
 Mitral regurgitation is the abnormal leaking of blood from the left ventricle, through the 
mitral valve, and into the left atrium during left ventricular systole. It can be brought on by a 
malfunction of any of the mitral valve components, leaflets, annulus, chordae tendineae, or 
papillary muscles, and occurs in three phases, acute, chronic compensated, and chronic 
decompensated. 
 Acute mitral regurgitation causes an abrupt volume overload of both the left atrium and 
the left ventricle. The left ventricle develops volume overload because with every contraction it 
pumps blood into the aorta (forward stroke volume), while blood regurgitates back into the left 
atrium (the regurgitant volume). The total stroke volume of the left ventricle (forward stroke 
volume plus regurgitant volume) increases with more regurgitation, which raises the percentage 
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of blood pumped from the left ventricle during one heart beat (ejection fraction). This increased 
ejection fraction deteriorates the left ventricular contractile function over time and thus 
eventually leads to a dysfunctional left ventricle with a decreased ejection fraction [10]. In 
addition, the regurgitant volume causes a volume and pressure overload of the left atrium, which 
inhibits drainage of blood from the lungs via the pulmonary veins and causes pulmonary 
congestion [10]. 
 Chronic compensated mitral regurgitation develops slowly. It is characterized by 
thickening of the left ventricle wall (hypertrophy) as an attempt to compensate for the larger than 
normal stroke volume. This hypertrophy, in conjunction with an increased diastolic volume, 
increases the stroke volume to higher than normal levels. As a result, the forward stroke volume 
approaches the normal levels in spite of the regurgitant volume. The volume overload of the left 
atrium causes enlargement of the left atrium chamber. The increased chamber size allows the left 
atrium filling pressure to decrease. This improves the drainage from the pulmonary veins and 
lowers the signs and symptoms of pulmonary congestion. So, these changes in the left ventricle 
and left atrium improve the state of the low forward cardiac output and the pulmonary 
congestion that occur in acute mitral regurgitation. Frequently, patients diagnosed with chronic 
compensated mitral regurgitation do not exhibit symptoms of regurgitation [10]. 
 Individuals with advanced stage chronic compensated mitral regurgitation are diagnosed 
with chronic decompensated mitral regurgitation. It is characterized by overload of the left 
ventricular contractile elements, calcium within the cardiac myocytes, resulting in left ventricle 
dysfunction [3, 10]. The ventricular muscles, myocardium, lose the ability to adequately contract 
and cannot compensate for the volume overload associated with mitral regurgitation. 
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Subsequently, the left ventricle stroke volume decreases and forces an increase in the end-
systolic volume that translates to increased filling pressures of the ventricle.  This once again 
leads to increased pulmonary venous congestion, which often results in symptoms of congestive 
heart failure. Furthermore, the left ventricle widens and causes an enlargement of the mitral 
valve annulus, which may worsen the degree of mitral regurgitation [10]. 
1.3.2 Aortic Valve Heart Disease 
1.3.2.1 Aortic Stenosis 
 Aortic stenosis transpires when the aortic valve narrows and prevents blood flow from 
the left ventricle to the aorta. It causes an increased pressure gradient between the left ventricle 
and the aorta. The more constricted the valve, the higher the pressure gradient. To compensate 
for the elevated pressure gradient, the left ventricle generates an increased pressure to drive 
blood into the aorta. This pressure overload results in left ventricle hypertrophy and, over time, 
produces a decline in systolic function. Aortic stenosis is the most prevalent form of 
cardiovascular disease in the Western world after hypertension and coronary heart disease [3]. 
1.3.2.2 Aortic Regurgitation 
 Patients suffering from aortic regurgitation experience blood leakage in the reverse 
direction of the aortic valve during ventricular diastole (from the aorta into the left ventricle). It 
is usually caused by abnormalities of either the aortic valve or the aortic root. When the pressure 
in the left ventricle falls below the pressure in the aorta, the aortic valve is not able to completely 
close, which means that forward stroke volume blood regurgitates back into the heart. The 
percentage of blood that flows back through the aortic valve due to stenosis is known as the 
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regurgitant fraction [3]. This causes a decrease in the diastolic blood pressure in the aorta, and, 
therefore, an increase in the pulse pressure (systolic pressure minus diastolic pressure). It 
ultimately leads to both a volume (elevated preload) and pressure (elevated afterload) overload 
of the heart. The pressure overload causes left ventricle hypertrophy and could eventually lead to 
more serious complications. 
 
1.4 Treatment of Left Heart Valve Disease 
1.4.1 Valve Repair  
Stenosis and regurgitation can generally be corrected via surgical procedures that either 
enhance blood flow, stenosis, or rectify closure inefficiencies, regurgitation. Most valve repairs 
conducted on the left heart involve the mitral valve and the applied surgical procedure ultimately 
depends on the diagnosis. Mitral valve repair techniques generally include:  
• Commissurotomy removes blood flow blockage caused by enlarged leaflets that 
may stick together. Surgery consists of severing the leaflets at their bonding point, 
which reopens the orifice and allows normal function to ensue. 
• Vavuloplasty is a reinforcement procedure that restores the complete closing 
ability of the valve. Annulus dilation is combated by implanting a cloth-covered, 
ring-like mechanism around the native annulus to provide support and return it to 
its original size. This brings the leaflets back into contact with each other. 
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• Reshaping compensates for leaflet elongation by a method commonly referred to 
as quadrangular resection. Unneeded, loose leaflet segments are removed and the 
remaining leaflet is sutured so as to fix closing complications. 
• Decalcification eliminates the calcium buildup from the leaflets and/or annulus, 
which increases the orifice area and restores function. 
• Chordae tendineae repair or replacement re-establishes the structural support 
of the valve by surgically shortening or using synthetic material, Gore-Tex, to 
replace the native chordae tendineae. Chordae tendineae may lose tension due to 
stretching or failure of papillary muscle function, but material length and function 
restoration permits valve closure. 
• Patching uses tissue sections to conceal valve apertures in the leaflet and/or 
annulus. 
Of these methods, only commissurotomy and decalcification are utilized in treatment of stenosis. 
Furthermore, more recent research focuses on the adaptation of percutaneous repair techniques 
[2, 11]. Several of these methods can also be used in aortic valve repair; however, they are 
infrequently attempted because of the technical difficulty involved. 
1.4.2 Valve Replacement 
Despite the success of left heart valve repair, patients with severe physiological 
impediment face complete native valve replacement as the only viable solution. Consequently, 
these “one solution” scenarios escalate the significance of effective replacement valve 
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development [2]. Since the first successful heart valve replacement procedure in 1952 by Dr. 
Hufnagel, there have been over 4 million, 300,000 annually, prosthetic replacement implants 
worldwide of over 50 developed artificial heart valve designs [4, 5]. These designs have 
effectively advanced the realm of heart valve research and are categorized into two major 
divisions, biological and mechanical. 
1.4.2.1 Bioprosthetic Valves 
Bioprosthetic replacements include, but are not limited to, valves taken from human 
donors as well as specified 
animals. The most widely utilized 
bioprosthetic valves have porcine 
origins or are constructed from a 
sheet of bovine pericardium that 
is cut to form valve leaflets and 
sewn into the valve structure [5].  
The first commercial porcine 
valve was the Hancock valve 
introduced in 1970. Since then 
additional bioprosthetic valves 
have been developed, using a 
variety of other biological 
material. They include bovine pericardial valves, Carpentier-Edwards Perimount, and equine 
tissue valves, original Cribier-Edwards. The Carpentier-Edwards Perimount valve is the only 
 
Figure 1.5. [5] Different models of bioprosthetic heart valves. 
(A)Medtronic HK II ultra porcine valve (with permission from 
Medtronic Inc). (B)Medtronic Freestyle porcine valve (with 
permission from Medtronic Inc). (C)Carpentier-Edwards 
Perimount bovine pericardial valve. (D)Edwards SAPIEN 
transcatheter pericardial aortic valve (courtesy of Edwards 
Lifesciences LLC, Irvine, CA, USA). 
13 
 
pericardial valve widely available in North America [5]. Most bioprosthetic valves are preserved 
in glutaraldehyde and mounted on a metal or plastic covered frame/stent with fabric that acts as 
the sewing ring. In cases where a larger than normal valve orifice is required, stentless 
bioprosthetic valves are used. These valves lack a stent/frame as part of their structure and thus, 
provide a larger effective orifice area and lower postoperative transvalvular gradients, compared 
to stented valves. In contrast to mechanical valves, bioprosthetic valves mimic native heart valve 
operation by providing unobstructed central flow. Figure 1.5 shows some well-known 
bioprosthetic valves. 
1.4.2.2 Mechanical Valves 
Currently, there are three 
main classes of mechanical 
valves, caged-ball, single leaflet 
or tilting-disk, and bileaflet 
valves. They are all comprised of 
three main elements: a closure 
mechanism (occluder), housing, 
and sewing ring. The first 
prosthetic heart valve was the 
Starr-Edwards caged-ball valve 
introduced in 1960. The original 
version of the Starr-Edwards 
valve utilized a free-ball design 
 
Figure 1.6. [5] Different models of prosthetic mechanical heart 
valves. (A)Starr-Edwards caged-ball valve (courtesy of Edwards 
Lifesciences LLC, Irvine, CA, USA). (B)Bjork-Shiley tilting-
disk valve (courtesy of Sorin Group of Canada Inc, Canada). 
(C)Medtronic Hall tilting-disk valve (with permission from 
Medtronic Inc, Canada). (D)St Jude Medical Regent bileaflet 
valve (courtesy of St Jude Medical Canada). 
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with a silicone rubber (silastic) ball that freely moved inside a three-strut alloy cage. Subsequent 
models had a metal ball and a four-strut cage. Following the Starr- Edwards caged-ball design, 
the single leaflet or tilting disk valve was pioneered in 1969 by Bjork-Shiley. It consists of a 
pyrolytic carbon disk that is stabilized by a large inflow and small outflow alloy strut and 
enclosed by a Teflon sewing ring. The Medtronic-Hall tilting-disk valve remains one of the most 
implanted valves of all time [5]. Even more utilized than the Medtronic-Hall tilting-disk valve is 
the St Jude Medical valve introduced in 1977 [5]. It was the first bileaflet valve and is made of 
two pyrolytic carbon coated leaflets, with graphite, that pivot on a ring and is encircled by a 
sewing ring. The St Jude Medical bileaflet valve is the single most implanted mechanical valve 
to date [5] and has been modeled to form several other commercially available bileaflet designs. 
Consequently, bileaflet valves are the most commonly used of the three main classes [5]. Figure 
1.6 shows some of the more prominent mechanical valves. 
 
1.5 Disadvantages of Prosthetic Heart Valve Implantation 
 Bioprosthetic valve replacements have exceptional histocompatibility, but are susceptible 
to problems attributable to natural degenerative effects [12]. Subjects who receive biological 
valve replacements often experience a recurrence of issues dealing with regurgitation or 
calcification, which often require additional surgery to repair or replace. For this reason, most 
bioprosthetic valves last approximately 15 or so years after implantation, making durability the 
major concern. 
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 In contrast to bioprosthetic valve replacements, mechanical valve replacements have little 
to no durability concerns. On the other hand, mechanical valves lack the excellent histologic 
characteristics of bioprosthetic valves [12]. As with the implantation of all foreign devices in the 
circulatory system, it is essential for mechanical heart valve replacements to keep normal blood 
flow disruption to a minimum. For this reason, patients with mechanical heart valves must 
constantly take blood thinner to reduce the potential of blood clot formation in and around the 
replacement valve. Research shows the chief factors that influence thrombus development are 
changes in vessel wall morphology, changes in blood flow through the vessel, and changes in 
blood composition [13, 14]. Since blood composition usually remains constant before, during, 
and after mechanical valve replacement surgery, the remaining two factors are the foundation of 
clot formation at the replacement site. Coincidentally, both morphology and blood flow 
variability depend heavily on the design of the replacement [15]. The morphology of the 
mechanical replacement valve does not change following fabrication; however, flow variability 
within the valve is a product of its morphology. Sudden changes in flow dynamics tend to have a 
negative impact on red blood cells by causing incidences of turbulent flow and flow separation. 
At these locations of flow disturbance, an amplification in the stress on red blood cells is noticed, 
which often lead to rupture (hemolysis) and platelet aggregation. Research support the use of 
certain design types over others based upon the design’s tendency to prompt flow turbulence 
[16]. Therefore, the way to control thrombus activity in the mechanical replacement valve is to 
incorporate design specifications that theoretically induce laminar flow while minimizing flow 
disturbances such as turbulence and flow separation. Furthermore, study results indicate area 
specificity in blood clot formation of existing mechanical heart valve replacement designs, 
especially at the struts of caged-ball and tilting disk valves and the hinges of bileaflet valves 
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[17]. These research results designate exact interest areas for improvement purposes and 
progression towards the continual goal of ideal histocompatibility, which implies little to no 
blood clot formation. Evidence of prior research confirms that, of the three chief mechanical 
models, bileaflet valves experience the least amount of clot formation. However, hemolysis and 
thrombosis continue to be major issues of concern in all mechanical heart valve (MHV) 
replacement designs. 
Both biological and mechanical prosthetic heart valves have made enormous progress 
over the years; however, improvements continue to be warranted because of shortcomings that 
include durability and the propensity to incite thrombosis and/or hemolysis [18]. The ideal, 
functional replacement valve will maximize biocompatibility while also minimizing longevity 
and histologic concerns. 
 
1.6 In Vitro Evaluation of Prosthetic Heart Valves 
In the case of MHV replacements, advancement towards an ideal design primarily centers 
on the evolution of proven existing, operable models. Researchers continuously search for ways 
to improve these models via the study of things such as prosthetic valve geometry and 
manufacturing material. Likewise, there is a constant need to assess flow when using newly 
renovated bioprosthetic heart valves.  In order to investigate these various artificial heart valves 
prior to implantation, it is necessary to recreate the natural valve in in vivo conditions so as to 
better assess the biofluid dynamics.  Therefore, the enduring pursuit of the ideal heart valve 
design is accompanied by the ever-changing development of an in vitro testing environment that 
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effectively simulates in vivo conditions. As previously stated, the majority of valve replacement 
procedures occur on the left side of the heart. For that reason, much of the valvular research 
concentrates there as well. These analyses serve as a method of evaluating the effects of the 
prosthetic valve biofluid dynamics on hemolytic and thrombotic activity before patient insertion. 
 
1.7 Research Aims 
Currently there exist several devices used to assess MHVs in a variety of mock 
circulatory loop setups. These tools readily provide information for in vitro MHV performance 
evaluation, including but not limited to thrombosis, hemolysis, and material failure. Translation 
of these concepts into a mechanism that allows for quicker and more efficient MHV 
interchangeability and hemodynamic condition manipulation will potentially improve upon the 
required time needed for assessment and comparative testing. The purpose of this research is to 
develop and validate an instrument and procedure for evaluating MHV replacements in the 
Artificial Heart Laboratory at Virginia Commonwealth University. The goals of this research 
include: 
• Design and construction of a quick, interchangeable MHV holding chamber 
• Implementation of the MHV holding chamber into a fully automated mock 
circulatory loop 
• Visualization of fluid flow through the test MHV at varying physiologic 
conditions 
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2   LITERATURE REVIEW 
 
Over the years, a major focal point of valvular investigation has been the effective 
performance testing of artificial heart valves (AHV) using proficient simulation of the native left 
heart environment. Several studies have been conducted to determine the causes and locations of 
valvular induced flow disturbances that may lead to hemolysis or thrombosis. These studies have 
been done on both FDA approved and unapproved designs as well as in comparative analyses 
that provide evidence of the advantages of one particular design over another. These research 
approaches have provided groundbreaking information used in AHV design. 
 
2.1 History of AHV In Vitro Test Results 
One major concept that was investigated early was the clinical affects of regurgitant 
backflow and low cardiac outputs on AHV performance.  Meyer et al [19] and Kini et al [20] 
have completed numerous experimental procedures on regurgitation backflow. They used their 
findings to effectively predict regurgitant leakage flow regions and correlated these locations 
with high magnitudes of Reynolds shear stress, which has been found to be a major factor in 
hemolysis. Similarly, Sabbath and Stein [21] conducted comparative analyses of four AHVs in 
order to investigate backflow and its relation to other cardiac elements. They stated that valve 
closure and leakage contribute, independently, to total valvular backflow measurements and 
primarily focused on the association between the amounts of total backflow of examined 
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prosthetic aortic valves when exposed to specific mean aortic pressures. Furthermore, they 
presented evidence of the effects of cardiac output on backflow and provided response 
measurements to changes in heart rate and/or stroke volume. They deduced that the risk of 
clinical significance is heightened when exposed to lower cardiac outputs, which was further 
explored by researchers such as Z. Wu and company. Wu et al [22] evaluated AHVs during low 
cardiac output conditions and found that valve size and closure volume were directly related to 
one another, meaning that increasing or decreasing one induces a similar response in the other. 
Therefore, designing AHVs with this in mind allows normal valve functionality at lower cardiac 
outputs. These studies advanced the significance of in vitro AHV evaluation under low cardiac 
output conditions and support the importance of regurgitation backflow. As a result, they greatly 
contribute to AHV design progression. 
Another notable investigative dynamic of valvular-induced fluid mechanics is the 
analyses of vortex and microbubble formation. Gross, Shermer, and Hwang [23] focused on flow 
fields distal to the prosthetic heart valve. They concluded that the distal flow was affected by 
valvular opening angle by relating the valve leaflets to a set combination of rectangular plates 
and utilizing prior airfoil studies to characterize them. Thus, factors such as drag force, lift 
coefficient, drag coefficient, and momentum coefficient were used to analyze the observed distal 
flow patterns and explain boundary layer flow separation at the end of the valve leaflet. The 
establishment of this relationship between the valve leaflets and earlier validated airfoil 
evaluations allowed Gross, Shermer, and Hwang to realize a trend stating that increased opening 
angle leads to increased flow separation and vortex shedding (i.e. turbulence). Moreover, Milo et 
al [24] expanded on Gross and company’s research by linking observed vortex regions to clinical 
complications such as left atrial wall mechanical damage, thrombotic issues, and inflammatory 
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reaction effects. In addition, they verified the isolated existence of microbubbles at mechanical 
valve closure and connected the event to the valve shutting process. These bubbles enhanced the 
potential of the blood to clot and made these locations, local and abroad, more susceptible to 
thrombosis. Conclusively, the observed results of these research endeavors, along with their 
clinical implications, were very important to AHV performance testing and led to improvements 
in future design and operation. 
Lastly, a principle clinical concern of heart valve analysis is the development of 
cavitation. Johansen et al [25] Manning et al [26] conducted an in depth analysis of vortices and 
regurgitant jets during the closure and rebound phases of MHV operation. They were able to 
associate these phenomena with potential cavitation growth and clinical implications based upon 
prior investigative studies done by others. One such prior investigative study was performed by 
Lamson et al [27]. Their research involved AHV cavitation pattern detection in real-time. 
Through this real-time detection process, they were able to characterize areas of replicating 
cavitation formation and develop a cavitation cycle that corresponds with that of the normal 
cardiac cycle. In addition, they plotted this cavitation cycle as a function of atrial pressure. The 
techniques developed in this study provided a means of exposing the causes and locations of 
cavitation formation during the usage of AHVs, which helps in the design and implementation of 
cardiac heart valves, drive systems, and/or device control schemes. 
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2.2 AHV Experimental Test Setups 
As stated above, a major component of the previously described research was the 
simulation of the native left heart environment. Several AHV assessment mechanisms only seek 
to reproduce natural flow conditions and do not take into account other anatomical feature 
effects. The majority of studies that employ this type of arrangement are focused on the 
performance of a particular AHV at very specific conditions and locations. However, for 
researchers that want to better replicate human physiology, a typical experimental setup consist 
of a mock circulatory loop in conjunction with an image capture apparatus. The common theme 
of these systems is their attempt to imitate native conditions so as to expose the trial AHVs to 
circumstances similar to those encountered after implantation. However, they have evolved over 
the course of time due to variability in study focus. 
2.2.1 AHV Test Chamber 
An investigator’s AHV test system is heavily based on the intended goals of their 
experimentation. For instance, Browne et al [28] neglected common components such as 
compliance and peripheral resistance. Consequently, the primary observation area of their 
experimental setup consisted of flow, supplied by a centrifugal pump, through a mounted AHV 
and into a clear, anatomically correct aortic root model where imaging was completed. Figure 
2.1 shows the Browne et al AHV test system. In this study, Browne et al were more focused on 
the imaging technique so the test arrangement was indicative of that focus.  
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Other examples of this type of arrangement were Meyer et al [19] and Kini et al’s [20] “single 
shot” chamber system shown in Figure 2.2. These groups sought to supply an all-inclusive 
interpretation of mechanical 
heart valve flow fields with 
both global and localized data 
[19, 20]. These experimental 
objectives permitted a fairly 
simplistic test chamber setup 
that consisted of a two 
compartment box connected on 
one side by a mechanical heart 
valve mounted in a constructed valve holder. The ventricle was represented by the smaller 
compartment, which was sealed and linked to a pneumatic pressure regulator system, and the 
atrium was the larger chamber that was open to the atmosphere. The pressure was controlled in 
the ventricular chamber so as to simulate the physiological systolic cycle where pressure was 
held constant to symbolize systolic duration and then released.  
 
Figure 2.1. [28] Diagram of mounted test valve and anatomically 
designed aortic model in Browne et al’s experimental setup. 
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Figure 2.2. [19, 20] Diagrams of Kini et al MHV test setup, Top View (top left) and Side View (top right). 
Diagram of Meyer et al MHV in mounting arrangement (bottom). 
 
Correspondingly, the test arrangement employed by Milo et al [24] for vortex evaluation was 
manufactured to imitate fluid flow during early systole, at the point where backflow is at its peak 
and immediately following heart valve closure. More specifically, they wanted to recreate the 
high velocity leakage through the narrow gap of the closed leaflets. To accomplish this, the 
experimenters used a single test chamber with a static valve mounted in the closed position and 
controlled fluid flow via a high-speed solenoid valve that connected to a regulated pressure 
basin. In addition, a microbubble generator was attached to the test chamber to produce hydrogen 
bubbles that served as tracers for vortex visualization. Milo et al’s experimental AHV test 
chamber is depicted in Figure 2.3. 
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Validation from prior literature 
supports the use of these arrangements 
in these scenarios and, thus, defends the 
significance of the acquired data in 
AHV performance research. However, 
it is recognized that these setups do not adequately depict the pulsatile flow or the peripheral 
resistance of the native cardiac system. Both of which notably affect blood flow. 
2.2.2 Mock Loop Testing 
Despite the success of the above mentioned studies, several researchers prefer the 
application of a more physiologically correct understanding. An early in vitro test arrangement, 
based on a larger version introduced by Davila, Trout, Sunner, and Glover in 1956, was utilized 
by Bjork, Intonti, and Meissl [29] to examine prosthetic mitral and aortic valves. In choosing this 
system, Bjork et al placed heavy emphasis on the ability to accurately simulate a variety of 
physiological conditions. The system contained a mechanical pulse duplicator and was equipped 
with the capability to adjust systolic-diastolic range and ventricular, atrial, and aortic pressure 
curve shape. The pulse duplicator, shown in Figure 2.4, had a closed loop arrangement with two 
independent, hydraulic components: 1. pumping system and 2. testing system. The pumping 
system consisted of a one-armed roller pump that regulated stroke volume and pulse rate via the 
manual control of RPM and tube occlusion. The testing system was the interconnected valve 
testing chambers, aortic analogue, peripheral resistance, and left atrium analogue. Manual 
mechanical adjustments of the testing system included changeable peripheral resistance and the 
height of the reservoir above the mitral valve chamber. 
 
Figure 2.3. [24] Milo et al AHV test chamber. 
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Bjork, Intonti, and Meissl utilized the 
positive outcome of this experiment to help 
establish the importance of simulating left 
ventricular, left atrial, and aortic 
physiological dynamics during in vitro 
evaluation of mitral and aortic cardiac 
valves. As a result, numerous ensuing AHV 
studies employed similar mock loop setups. 
These latter studies often had relatively 
minor modifications such as a human-shape 
molded, collapsible rubber sac for the left 
ventricle and a calf aortic root mold with the Sinus of Valsalva in place of the aortic analogue 
[21]. In spite of these modifications, the system consistently produced overall static performance 
results. 
Eventually, as a better understanding of natural cardiovascular simulation was developed, 
several elements of the aforementioned mock circulatory loop were eliminated. Conversely, new 
components were added such as programmed waveform generators [30]. Johansen et al [25] used 
a mock loop with an Electric Ventricular Assist Device in conjunction with mechanisms to 
simulate atrial and venous compliance. While these compliance chambers were not found in the 
Bjork et al setup, Johansen et al also utilized identical key features such as systemic resistance 
and a venous reservoir. Pressure tranducers and flow probes were positioned at specific locations 
in the loop to better monitor and facilitate fluid flow. Lastly, the loop contained a bubble filter to 
 
Figure 2.4. [29] Pulse duplicator. L.A.=left atrium; 
M.V.=mitral valve; L.V.=left ventricle; A.V.=aortic 
valve; A=elastic container; B=rigid container; 
P=pump; P.R.=peripheral resistance. 
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remove air bubbles from the blood analog fluid that may negatively affect observation results. A 
diagram of Johansen et al’s test system is seen in Figure 2.5. 
 
Figure 2.5. [25] Diagram of Penn State EVAD and mock circulatory 
loop with the location of observation equipment, filter removes air 
bubbles from blood analog fluid. 
 
Further progression of AHV test arrangements included increasingly more anatomically 
correct structures. Milo et al [24] used a pulsed flow simulator with anatomically oriented 
mounts for the mitral and aortic valves that functioned to reproduce physiological conditions.  
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This simulator is illustrated in Figure 2.6 
and was comprised of five major components, a 
positive displacement pulsatile pump with a 
physiologic waveform generator, a left ventricular 
compartment, a couple of autonomous pressurized 
containers for systemic compliance and peripheral 
resistance, and an open atmosphere venous 
reservoir that was connected to the other 
components through an adjustable resistance 
mechanism. 
The discussed research provides an 
indication of the vast amounts of AHV mock loop 
experimental setups. Even as these systems progress, they consistently have the common primary 
objective of exposing the test AHV to a range of native physiological conditions using a bench 
top entity. This application is crucial to AHV design characterization. Although the described 
mock loops accomplish this major system objective, there continues to be room for 
improvement. The time demands and task intensiveness of manually controlling mock loop 
parameters suggest significant research progression with automated mock circulatory loop 
development.  In reference to AHV test research, it will advance performance and comparative 
test methods, especially in conjunction with an AHV holding chamber that permits speedy valve 
interchangeability. 
 
Figure 2.6. [24] Photograph of left heart 
pulse simulator used for bubble formation 
detection. LV=left ventriclular sac; 
MV=mitral valve; MC=mitral channel; 
AV=aortic valve; AC=aortic channel 
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2.2.3 Flow Visualization 
 During AHV mock loop and/or test chamber performance analyses, researchers utilize 
several techniques to capture the observed flow field profile data. Following image capture this 
information is stored and properly interpreted using a number of computer software. These 
applications provide better understanding of flow as it correlates to theoretical assumptions and 
assist in AHV design modification. An early method used by Lamson et al [27] included a 
specialized pressure transducer to 
identify valve closure and trigger a 
strobe flash. The strobe flash 
contained a photodiode to activate 
an image capture/storage system 
with a high resolution CCD 
camera. In the case of this study, 
the major issue with this imaging 
technique was the associated time 
delay. Therefore, Lamson et al had 
to calculate and document time 
delays for all triggering mechanisms and the system as a whole in order to interpret the data in 
real time. Figure 2.7 shows Lamson et al’s flow visualization system. 
Although Lamson et al were able to use the arrangement described above, there are 
several other techniques used in AHV fluid flow data acquisition, including hot-wire 
anemometry, dye tracing, laser Doppler velocimetry (LDV), and particle image velocimetry 
 
Figure 2.7. [27] Zoom in diagram of valve, viewing port in 
mock circulatory system, and instrumentation for cavitation 
observation. 
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(PIV). The latter three are based on indirect flow measurements that track an external agent 
within the fluid flow, particles or dye [31]. These agents flow with the researched fluid without 
differing in direction or magnitude from the fluid velocity, which allows for accurate recordings 
[31]. Hot-wire anemometry uses temperature and electrical resistance. 
2.2.3.1 Hot-Wire Anemometry 
 Hot-wire anemometry is a relatively easy and inexpensive technique that provides 
extremely high frequency-response and fine spatial resolution; however, the utilized devices are 
exceedingly delicate. Hot-wire anemometers are devices used to measure the variables occurring 
in turbulent flows, such as mean and fluctuating velocity  components, mean and fluctuating 
temperature, etc. The sensors are thin metallic elements heated by an electric current and cooled 
by the incident flow, which acts by virtue of its mass flux and its temperature. From the 
temperature (or resistance) attained by the sensor, it is then possible to deduce information on the 
flow. More than one sensor, or more than one value of the heating current, is often necessary to 
investigate thoroughly a turbulence flow [32]. 
2.2.3.2 Dye Tracing 
 Dye tracing uses dye or a chemical reaction to track fluid flow in order to analyze flow 
patterns.  This visualization method provides qualitative data and works best with laminar flow 
profiles that maintain streamlines for imaging [33]. Turbulent flow profiles mix the dye lines and 
make characterization very difficult. Dye tracing requires using dye that follows fluid flow 
without incident, meaning that it has the same density as the investigated liquid [33]. The dye is 
also injected into the flow field at a rate that is proportional to the fluid velocity [33]. Sometimes 
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photo dyes are used that fluoresce when encountered by light [33]. Images are captured using a 
high speed camera to measure the travel distance of the dye. 
2.2.3.3 LDV and PIV 
The advantages and disadvantages of the LDV and PIV methods have been heavily 
examined. Browne et al [28] conducted a comparative study of these two techniques via an AHV 
steady flow investigation. The setups for each process, LDV and PIV, are shown in Figures 2.8 
and Figures 2.9, respectively. Three major steady flow elements, vorticity, maximum turbulent 
principal stress, and maximum turbulent shear stress, were computed using previously 
formulated equations and data from both the LDV and PIV processes. In comparing LDV data 
and PIV data, including but not limited to contour plots, Browne et al concluded that PIV 
imaging works well for purposes of gathering quantitative data in an entire flow field and LDV is 
better suited for obtaining more accurate, quantitative data in specific, localized areas. They 
supported this conclusion through their experimental results in which agreement between the two 
imaging techniques were found in the formation of mean velocity profiles but discrepancies were 
seen in areas of high turbulence, including locations of maximum normal stress and maximum 
turbulent shear stress. At these turbulent regions the PIV values were significantly higher than 
the LDV values; thus, presenting ambiguity when using PIV for turbulent flow applications. 
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Figure 2.8. [28] Diagram of the Browne et al LDV equipment setup (left) and LDV vector density plot 
(right). 
 
 
 
Figure 2.9. [28] Diagram of the Browne et al PIV equipment setup (right) and PIV vector density plot 
(left). 
 
 Based upon conclusions similar to those made by Browne et al concerning the PIV and 
LDV processes, Kini and company [20] deduced that the best imaging procedure would be one 
that eliminated the negative aspects of each by combining their positives. They decided to merge 
the point-based LDV and the plane-based PIV to provide an extremely advantageous flow 
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analysis that delivered whole-field fluid velocity information as well as high levels of accuracy 
and resolution. The findings of this study included a clear, spatial illustration of flow patterns 
associated with valve occluder motion during closure, rebound, and sustained leakage phases as 
well as local, temporal variations in flow. These PIV and LVD interpretations were key in 
determining the effects of AHV design on fluid flow, which, consequently, permits prediction of 
areas that may cause in vivo hemolyisis, thrombosis, cavitation, etc. Accordingly, these LDV and 
PIV imaging results defended Kini et al’s argument that the application of both techniques 
enhances the ability to interpret flow information when compared to the utilization of either 
technique independently. 
 Both the LDV and the PIV procedures are tremendously valuable in AHV performance 
evaluation research. The combination of these imaging techniques supplies an all-inclusive 
interpretation of AHV flow fields with both global and localized data. On the contrary, the 
independent application of either LDV or PIV for flow visualization also provides very 
beneficial flow data, which can be sufficient depending upon the investigative objectives. For 
that reason, this research employs the independent PIV image capture method because it 
provides quantitative information of the entire flow field, which satisfies the thesis goal. 
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3   METHODS AND MATERIALS 
 
3.1 Mock Circulatory Loop 
As previously stated, the implementation of a mock loop to replicate the human 
circulatory system is essential to AHV testing. Therefore, a mock loop was developed similar to 
those utilized in prior cardiovascular research studies but with numerous modifications that 
improve loop test efficiency. Figure 3.1 depicts the basic components of this mock loop which 
include a tank to serve as the venous reservoir, quick disconnect mechanisms, a pump to operate 
as the heart, a heart valve testing chamber, a capacitor and a resistor to represent arterial 
compliance and peripheral resistance, respectively. These components are connected via 1 ¼” 
outside diameter (OD) and ¾” inside diameter (ID) tubing that act as the native system 
vasculature. In addition, several monitoring devices were installed in the mock loop so as to 
measure a variety of circulatory system parameters. The loop is assembled in a water-resistant 
wood basin that isolates the loop fluid path in case of leakage. Figure 3.1 shows the diagram and 
illustration of the mock circulatory loop. With the exclusion of the heart valve test chamber, 
design and implementation of these mock loop components were completed by Charles Taylor 
with help from other members of the Artificial Heart Laboratory at Virginia Commonwealth 
University [35]. 
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Figure 3.1. Mock circulatory loop. 
 
3.1.1 Venous Reservoir 
The container used as the venous reservoir is an acrylic box (6” x 6” x 6”) with ½” wall 
thickness and a top open to the air. Figure 3.2 shows the acrylic venous reservoir with one inlet 
and two outlet ports. The inlet port to the reservoir is centered 3” from the top edge along one of 
the cube faces that lies orthogonal to the open face of the acrylic box. Outlet Port 1, labeled as 
such in Figure 3.2, is located on the cube face directly across from the inlet port in the identical  
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geometric position as the 
inlet port on its respective 
cube face. Outlet Port 1 leads 
to the inlet of the pulsatile 
pump. The other outlet port, 
Outlet Port 2 in Figure 2.2, is 
stationed 1.5” from the 
bottom edge on an adjacent 
cube face relative to the inlet 
port side. This port leads to 
the inlet of the left ventricular assist device (LVAD), which, if applicable, is the steady-flow 
multiple disk centrifugal pump (MDCP). The backside of the container, only face without a port, 
attaches to a support laser rail. Figure 3.2 depicts the mock loop venous reservoir. The venous 
reservoir is filled with fluid to a level just above the inlet, to ensure that the entire loop is 
completely filled and rid of air bubbles. Adjusting the fluid level in the container and/or the 
height of the container itself will vary the arterial pressure of the system. Lastly, a magnetic 
stirrer is stationed beneath the venous reservoir in order to maintain a homogenous mixture when 
required. 
 
Figure 3.2. Mock loop venous reservoir. 
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3.1.2 Quick Disconnect System 
In between each of the 
outlet ports and their respective 
pump is a quick disconnect 
mechanism, as seen in Figure 
3.3. The quick disconnects in 
this mock loop serve as flow 
facilitators for the system. 
They provide independent 
detachment for various loop 
components without having to 
drain the entire system. Each disconnect site consists of a metal on metal cam-and-groove hose 
coupling in conjunction with a low-pressure PVC dual ball valve, which  controls flow through 
the system inner diameter. These preserve the free flow path of the mock loop, while also 
allowing reasonably swift interchangeability of loop elements without complete system drainage. 
As a result, the quick disconnect application reduces spillage and diminishes manual effort 
commonly associated with experimental setup. 
3.1.3 Pulsatile Pump 
Outlet Port 1 of the system venous reservoir leads to the inlet of the pulsatile pump. The 
pump in this study, which mimics heart function, is a modified Harvard Apparatus Pulsatile 
Blood Pump 1423. This self-priming pump is a respected benchmark standard in hemodynamic 
research that seeks to imitate the large animal cardiovascular system. It features a mechanically 
 
Figure 3.3. Mock loop quick disconnect mechanism. 
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activated piston that oscillates within a clear cylinder hub. The pump design leaves minimal 
blood cell damage when utilized with whole blood and completely empties the cylinder hub with 
each stroke, despite the selected stroke volume. It has two caged ball valves located at the inlet, 
mitral, and outlet, aortic, positions, which facilitate laminar flow through the piston-hub, left 
ventricle, without incidence. The fluid flow paths of the pump can be dismantled and sterilized 
when applicable. Stroke volume (SV) and heart rate (HR) are dynamically adjustable during 
operation with a range of 15 to 100 mL and 0 to 95 beats per minute (BPM), respectively. This 
research modeled several stroke volume-heart rate combinations at a 50% systolic ratio, where 
the piston speeds during filling and emptying are identical. These varying conditions are 
indicative of the wide range of physiological situations. Harvard pump modifications by Charles 
Taylor et al in the Artificial Heart Laboratory at Virginia Commonwealth University include 
novel conversion of manual pump adjustments to complete automation. This transformation 
required preliminary computational studies in order to gain a better comprehension of the pump 
motor speed profile during several HR and systolic ratio stages [35].  Observation of the piston-
driving shunt motor’s voltage and current values throughout operation and the systolic/diastolic 
analog feedback presented an improved understanding of the drive motor in relation to the 
pumping phase [35]. These introductory investigations assisted in the selection and 
implementation of a replacement motor driver board that created opportunity for external control 
of the Harvard Pulsatile Blood Pump 1423. Furthermore, several novel parts were machined 
and/or purchased and then applied to advance pump automation including a linear slide 
potentiometer (Panasonic), Spur Gear 32 Pitch (McMaster-Carr), and Compact DC Gear Motor 
12 VDC, 50 RPM (McMaster-Carr) for SV manipulation [35]. After successful pump automation 
development, the system stroke volume and heart rate were calibrated accordingly. Additional 
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pump alterations include removal of the silicon ball in the outlet pump valve so as to incorporate 
the tilting disk MHV into the loop farther downstream, which suggests aortic valve native 
orientation. 
3.1.4 MHV Test Chamber 
 As fluid is pumped out of the Harvard pulsatile pump, it flows into the MHV test 
chamber. The chamber serves as the center piece for image capture in this research. It holds the 
test heart valve in position within the mock loop and allows fluid to pass through the device 
mimicking blood flow from the left ventricle to the aorta via the native mitral valve. The test 
chamber consists of inlet and outlet polycarbonate tube sections with a middle collar that 
securely pinches the annulus of the MHV so as to anchor the valve at the designated location. 
The collar was designed to operate with a 25 mm tilting disk valve, but will theoretically 
function with any 25 mm MHV type. The collar is comprised of two stainless steel halves with a 
1 ½” radius and 0.170” thickness. Each half contains two 100 degree countersink, #8-32 screw 
through holes, which allows it to fasten to a 1/8” anchor disk that is positioned just proximal to 
the valve entrance. During complete assembly, the test MHV, tilting disk valve, is wedged 
between the collars and firmly attached to the anchor disk, which securely keeps the valve in the  
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correct orientation. 5/16” diameter holes were created to allocate implementation with other 
mock circulatory loop components 
and the inlet and outlet connections. 
The center hole of the collar was 
constructed to mate with the outer 
annulus of the valve.  Figure 3.4 
shows the SolidWorks model of the 
collar section with the anchor disk. 
The MHV test chamber inlet and 
outlet features are made of 4” 
polycarbonate tubing with 1 ¼” 
inner diameter with 1/8” wall 
thickness. This tube was fixated, using Weld-On adhesive, to a 1/8” thick, 3” diameter 
polycarbonate disk with 5/16” diameter through holes for bonding to the collar using wide, flat-
head #¼-20 bolts with nuts. Figure 3.4 depicts the exploded SolidWorks assembly model. 
Computational fluid dynamics were used to simulate fluid flow through the model prior to 
manufacturing. Figure 3.5 illustrates the MHV test chamber in the mock loop. Gasket material 
was placed between all contacting surfaces in order to discourage leaking incidence. In addition, 
tube holders were utilized at the inlet and outlet sections to stabilize the chamber during imaging. 
 
Figure 3.4. SolidWorks models of 25mm valve collar (top 
left), inlet/outlet MHV testing chamber (bottom left), and 
exploded view of MHV testing chamber assembly (right). 
40 
 
 
Figure 3.5. Mock loop MHV holding test chamber. 
 
3.1.5 Compliance Chamber 
Following closure of the aortic valve, tension forms in the dilated aorta because of the 
sudden force increase against the aortic wall 
due to the abrupt change in blood volume and 
pressure. This tension of the elastic vessel 
wall propels blood through the circulatory 
system after it is pumped from the heart. The 
compliance chamber used in this experimental 
mock loop is a lumped parameter that 
emulates the elasticity of all blood vessels in 
the native circulatory system and is shown in Figure 3.6. When the Harvard pulsatile pump 
 
Figure 3.6. Mock loop compliance chamber. 
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delivers blood to the chamber, during systole, the elastic membrane inside the chamber expands 
and fluid is temporarily stored until the tilting disk valve closes to allow the pump to fill, during 
diastole. The stored energy in the membrane then pushes the fluid through the loop.  The 
compliance chamber consists of a 5.5” hollow diameter cylinder with ¾” wall thickness and 6” 
height. It splits into two sections, top and bottom. The top section contains a ½” metal plate with 
a pressure valve that feeds and extracts air in and out of the top of the chamber when assembled 
using a mobile air compressor. This metal plate also has a notched center that adapts with a 
nonconductive composite toggle clamp that allows for a uniform compression mate of the top 
and bottom chamber sections. The bottom section has inlet and outlet rigid glass tubing that 
enables fluid flow in and out of the chamber, in addition to a platform that attaches to a laser rail. 
Lastly, a supplementary pressure valve in the bottom section is used to expel air pockets from the 
loop, if needed. During complete compliance chamber assembly, the two sections are separated 
by a Thera-band membrane cartridge. The Thera-band cartridge pulsates with a consistent elastic 
behavior as fluid flows through the bottom of the chamber and drives it through the loop, thus 
mimicking arterial compliance. Air pressure above the Thera-band cartridge, in top chamber 
section, provides resistance to Thera-band pulsation. As more air is introduced into the top 
chamber via the pressure valve, opposition to Thera-band movement increases and the 
membrane becomes more resistant to fluid flow. Furthermore, Thera-band flow resistance is 
variable with material thickness, which is indicative of its elastic modulus. Different Thera-band 
thicknesses, denoted by color, were biaxially tested for strength using a MTS machine and 
developed into the interchangeable cartridges [35]. The combination of digital pressure-control 
in the top chamber and Thera-band selection permits fast mock loop compliance manipulation. 
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3.1.6 Resistor 
The fluid resistor of the mock loop is shown in Figure 3.7 and represents the total 
peripheral resistance of the circulatory system. Increasing or decreasing the resistance of the 
mock loop increases or decreases the pressure in the compliance chamber, which represents 
arterial pressure.  
This change in arterial, aortic, pressure 
modifies the pressure gradient across the 
aortic valve (transvalvular gradient). A 
modified transvalvular gradient is a common 
indication of VHD. The resistor in this loop is 
made of an aluminum rectangle (4” x 3” x 2”) 
with a ¾” diameter tunnel to facilitate fluid 
flow within the loop. This tunnel is impeded by a 1 ½” diameter solid aluminum cylinder that 
translates on a path oriented orthogonally to the flow path. The cylinder is secured to a linear 
stepper motor made by Anaheim Automation that internally converts rotary motion to linear 
motion. In doing so it supplies a thousandth of an inch travel per step. The digital adaptability of 
the motor allows for computational guidance of linearly transverse flow resistance via effective 
regulation of cross-sectional area [35]. This allows for highly efficient and effective dynamic 
control of the system resistance, which leads to the formation of physiological pressure 
conditions indicative of a wide range of pathologies. Fluid flow through the resistor was 
evaluated using computational fluid dynamics (CFD) prior to implementation [35]. Furthermore, 
 
Figure 3.7. Mock loop resistor. 
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the range of resistor positions was 0 to 450 with a 0 setting indicating zero flow occlusion and a 
450 setting indicating complete flow occlusion. 
3.1.7 Instrumentation 
 Several monitoring devices were present throughout the mock loop. They are used to 
capture quantitative data during the experimental process such as flow velocity and pressure 
value. 
3.1.7.1 Flow Meter 
 Flow meters acquire average fluid velocity rates at particular instances in time. The flow 
meter in this research was a H20XL-Sterile Tubing Flow Sensor manufactured by Transonic 
Systems Incorporated and is shown in Figure 3.8. It clamps around the mock loop tubing and 
employs ultrasonic transit time technology to measure the time difference of ultrasonic pulses 
transmitting in and against the fluid flow direction [34]. This time difference is a measure of the 
fluid average velocity along the ultrasonic beam path and can therefore be used to calculate the 
averaged fluid velocity [34]. The flow sensor was calibrated to the utilized tubing and water-
glycerin blood analog via an investigative test. This test consisted of a small mock loop with 
reservoir and steady flow pump that drove the blood analog through a section of tubing. The 
outlet of the pump emptied into a graduated beaker. A fluid volume gradient was selected prior 
to pump activation start and end volumes. After pump initiation, the time it took for the analog to 
rise between the start and end volume was manually measured and a flow rate was calculated 
accordingly. The calculated flow rate was then compared to the calculations of the H20XL-
Sterile Tubing Flow Sensor. This procedure was repeated 5 times and the results were averaged 
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to ensure accuracy and consistency of the method. Following linear fit to produce a calibration 
formula, the entire flow sensor 
calibration method was 
repeated using a higher 
pumping RPM to produce a 
variable fluid flow rate. The 
total calibration consisted of 2 
different fluid flow rates 
replicated 5 times each. 
During mock loop 
experimentation, frequency 
responses and flow rates were acquired between the MHV holding chamber and the compliance 
chamber inlet in Hertz and L/min, respectively. 
3.1.7.2 Pressure Transducers 
Two types of pressure transducers were inserted at numerous locations in the mock loop to 
provide pressure value measurements at any given time during experimentation. These 
transducers are pictured in Figure 3.9. The Omega pressure transducer (PX203-015G5V) was 
utilized in a series connection between the inlet and outlet valves of the air compressor to 
measure pressure levels in the top section of the compliance chamber. It has internal calibration 
done by the manufacturer with confirmed accuracy. However, this internal calibration was used 
to develop a calibration formula relative to the proportional opening and closing of the inlet and 
 
Figure 3.8. Mock loop H20XL Sterile Tubing Flow Sensor. 
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outlet pressure valves by reading displayed pressure values at correlating valve opening orifice 
positions. The other pressure transducers in the loop are made by Entran Sensors and Electronics. 
They are miniature sensors that are mounted flush 
against the wall of glass inlet and outlet tubings of the 
compliance chamber and the bottom section of the 
compliance chamber. The transducer in the glass inlet 
tube of the compliance chamber (99G99F22-X14) 
acquires pressure measurements of fluid prior to entry 
into the compliance chamber. And the sensor embedded 
in the bottom section of the compliance chamber gives 
pressure levels inside the chamber. The transducer 
located in the outlet glass tube of the compliance 
chamber was inserted but not used in this research. The 
Entran pressure transducers were effectively calibrated 
using a technique that formed calibration formulas from 
acquired data relating difference in fluid volume with displayed pressure and voltage values. All 
pressure sensors present data in mmHg. 
3.1.8 Computer Control and User Interface 
 Drivers for the loop components are controlled via a single computer workstation. This 
station links to an electronic control tower that houses all of the system data acquisition circuitry 
and power supplies. The workstation contains the Labview 8.5.1 virtual instrument developed by 
National Instruments that serves as the graphical user interface of the system. This software has a 
 
 
Figure 3.9. Mock loop pressure 
transducers, Entran (top) and Omega 
(bottom). 
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“dashboard” that consists of all the control buttons and simulated waveforms during loop 
operation. The control tower also has the digital meters of the measurement devices installed 
throughout the loop. These digital meters convert analog signals to electrical pulses which are 
transformed to digital outputs via the data acquisition board. Labview uses a data acquisition 
driver called NI-DAQmx to communicate with the external data acquisition board. The Harvard 
pump driver utilizes a PIC microcontroller and has a serial to USB cable. The PIC 
microcontroller was chosen due to its low cost, wide availability, and serial programming 
capabilities. Lastly, the pressure regulator valves that control the compliance chamber pressure 
have a control loop feedback mechanism known as a proportional integral derivative, PID, 
controller. The PID controller calculates an "error" value as the difference between a measured 
process variable and a desired set point. The controller attempts to minimize the error by 
adjusting the process control inputs. Figures 3.10 shows the developed Labview control 
dashboard. 
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Figure 3.10. Labview control dashboard. 
 
3.2 Blood Analog 
 The blood analog used in this research was a 60% water and 40% glycerin mixture. This 
blend is widely utilized in mock loop flow visualization applications due to its prior-validated 
ability to closely mimic real blood properties, especially density and viscosity. It has a density of 
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1.122 g/mL and a viscosity of 0.00485 N-s/m2 (4.85 cP), whereas whole blood has density of 
1.06 g/mL and viscosity of 0.0027 N-s/m2 (2.7 cP) [33]. Unlike whole blood, this substitute fluid 
provides the advantage of being readily available while eliminating storage issues and blood-
borne disease safety concerns. Furthermore, this mixture effectively follows a Newtonian fluid 
characterization, which is also indicative of whole blood in most arteries [33]. For these 
instances, whole blood shear stress linearly relates to deformation rate and its viscosity can be 
assumed to be a constant of approximately 4 cP [33]. The blood analog was mixed in a large 
glass graduated beaker by liter (600 mL water to 400 mL glycerin). In addition, the refractive 
indices of the blood analog and polycarbonate tube were matched to reduce light refraction at the 
test chamber-fluid interface. 
3.2.1 Density 
 Blood analog density was effectively measured via a standard hydrometer, which is 
pictured in Figure 3.11A. This instrument utilizes the Archimedes principle to determine relative 
density. The Archimedes principle states that the force required to float a solid suspended in a 
fluid is equal to the weight of the fluid displaced. Therefore, the lower the test fluid density then 
the further down the hydrometer will sink. The procedure for blood analog density measurement 
involved of pouring a specific amount of liquid into a graduated cylinder and gently lowering the 
hydrometer down into the cylinder. Once the hydrometer stabilized in the blood analog fluid, the 
measurement was read. The hydrometer is made of glass and consists of a cylindrical stem with a 
mercury-weighted bulb to ensure upright buoyancy. 
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3.2.3 Viscosity 
 Following calculation of blood analog density, blood analog viscosity was determined 
using the density result and an Ostwald viscometer, shown in Figure 3.11B. The Ostwald 
viscometer consists of a U-shaped glass tube with two bulbs and a vertical section that has a 
precise narrow bore (the capillary). The smaller bulb is located above the capillary section and 
the larger bulb sits towards the bottom of the other arm in the U-shaped design. The test blood 
analog was drawn into the small bulb via suction and allowed to flow down into the larger bulb 
using gravitational forces. Two red marks are positioned on the glass tube, above and below the 
small bulb, which designates a known fluid volume. As the blood analog flows through the small 
bulb, from the upper red mark to the lower red mark, the decent of the fluid level is timed via a 
standard stop watch timing device. Inputting the measured flow time and the previously 
calculated blood analog density into the following equation yields the blood analog kinematic 
viscosity. 
Viscosity (cP) = drain time (sec) * viscosity constant (cSt/sec) * density (g/mL) 
 
Figure 3.11. Standard hydrometer (A.) and Ostwald viscometer (B.). 
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3.3 PIV 
3.3.1 Hardware  
In this experimentation the PIV system was used for fluid flow pattern analysis. A thin 
and intense laser light sheet was used to illuminate neutrally buoyant particles in a 2D flow field. 
The particles scattered light from the laser which was imaged using a charged coupled device 
(CCD). The PIV system combines hardware components with a software application and a 
typical setup is pictured in Figure 3.12. The incorporated hardware includes a laser with power 
supply, camera, synchronizer, and computer. 
 
Figure 3.12. [33] PIV system setup. 
 
3.3.1.1 Laser with Power Supply 
 The laser in this experiment is a dual mini Nd: YAG laser manufactured by New Wave 
Research. It produces a doubled Q-switched beam by generating short duration (4-20 
nanoseconds), high energy (12 mJ) pulsed 532 nm light. The pulse energy is high enough to 
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illuminate the sub-micron particles in the water/glycerin fluid within the mock loop and the pulse 
duration is short enough to freeze flow motion. The laser uses a flashlamp mechanism to produce 
the pulse energy that transforms into the simulated laser beam [37]. The flashlamp firing 
frequency is 15 Hz. The dual lasers are equipped with power supply units and triggers from New 
Wave Research and connect to the synchronizer via color-coded connectors that denote the Q-
switch and flashlamp. 
 The generated cylindrical laser beam is converted into a thin lightsheet using optics 
located in the laser head. The optics consists of a cylindrical lens to diverge the beam in the 
height direction and a spherical lens to control the lightsheet thickness. The cylindrical lens has a 
negative focal length, with smaller focal lengths producing faster lightsheet divergence, while the 
spherical lens focal length is usually much longer [37]. Selection of each lens is done 
independently of the other and has significant effects on the lightsheet formation. Lightsheet 
cross sectional area is inversely related to its intensity and light intensity is directly related to 
particle illumination. So a lightsheet with large cross sectional area will not be able to expose the 
particles for image capture. For optimal experimental results, the laser is positioned, relative to 
the imaging area, at the focal distance of the spherical lens [37]. This focal distance is the 
lightsheet thickness waist, where the lightsheet is thinnest. In addition, lightsheet dimensions 
greatly influence variation in beam intensity across the imaging area. Hence, a short focal length 
spherical lens produces a very thin lightsheet but a relatively large intensity gradient, which will 
not create uniform particle illumination across the image area. The cylindrical lens used in this 
experiment had a -15 mm focal length and the spherical lens had a 500 mm focal length with 25 
mm diameter. Also the laser optics were oriented so as to produce a beam angled at 15.3 degrees 
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from the horizontal. This optic tilt complimented the tilt of the CCD camera in order to create a 
laser path orthogonal to the camera lens focal point, which is essential in PIV application. 
3.3.1.2 Camera 
 The system uses a CCD camera, PIVCAM 10-30, manufactured by TSI Incorporated. It 
captures pictures of illuminated particles in the fluid flow path and, in conjunction with the 
computer, processes a digital image. The camera functions by converting light energy into 
electrical energy and generating an electrical signal that is then sent to a Frame Grabber in the 
computer, where it is digitized [37]. The digitized information is finally passed to the computer 
system for processing and visualization on the monitor. The PIVCAM 10-30 obtains laser light 
scattered by particles, with a maximum frame rate of 30 Hz, using a CCD array of 1008 x 1018 
pixels. It contains a 550 nm filter attachment that improves imaging and maintains device 
functionality via background noise filter, glare filter, and CCD saturation avoidance. The 550 nm 
filter only passes wavelengths above 550 nm. Therefore, for adequate particle illumination light 
must be scattered at a wavelength above this threshold to be visible [37]. Nikkon AF-Nikkor 28 
mm and 50 mm lenses were used during experimentation with camera aperture setting of f/11. 
Aperture selection is critical for PIV photography because it significantly affects the particle size 
recorded on the CCD sensor (diffraction limited spot size), the object focus range (depth of 
field), and particle illumination. Particles used in this research were manufactured by Duke 
Scientific Corporation. They were hollow glass spheres with 1.05 to 1.15 g/mL density range and 
8 to 12 µm mean size range. The PIVCAM 10-30 was operated in triggered exposure mode with 
a sequenced capture and oriented orthogonal to the laser beam. 
 
53 
 
3.3.1.3 Synchronizer 
 The PIV synchronizer is a programmable timing mechanism that is designed to control 
the operation of the complete PIV system. It is the timing master of the system and manages all 
timing events needed to make PIV measurements [37]. The PIV measurement process requires 
that the different system components, camera, the laser flash lamps and laser Q-switches, are 
precisely time coordinated via the execution of programmed time sequences. These sequences 
distribute command signals to the camera, laser and other external devices (if applicable). A 
choice of automatic and manual configurations is available, covering a large range of 
experimental situations from single image acquisition to multi-sequence image bursts, phase-
locked operation, internal or external triggering. In this experiment, the synchronizer was 
triggered by an external TTL signal that was set to coincide with specific time points in the 
generated PIV data. Therefore, images were instantaneously matched with correlating pressure 
and flow curve position. In addition, the synchronizer communicates with the other PIV 
hardware using TTL signals. 
3.3.1.4 Computer 
 Research utilized a Dell Pentium 4 PC with 512 MB RAM. It contained a 40 GB hard 
drive and 1.2 GHz processing speed. The computer communicates with the CCD camera via the 
frame grabber which reads the image from the camera and displays it as a digital image on the 
monitor. These images are stored in the RAM and processed using the Insight 3.2 PIV software. 
Also, the computer is connected to the synchronizer by a RS232 serial cable connection. 
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3.3.2 Image Acquisition and Processing 
In order to obtain accurate PIV measurements using the aforementioned hardware, TSI 
Inc. provided a suggested set of rules in its PIV owner manual [37].  
1. The interrogation spot should be small for one vector to describe flow in a single 
interrogation spot. This will ensure less averaging, less noise, and good spatial 
resolution. 
2. There must be more than ten particle image pairs in an interrogation spot. Fewer 
particles per interrogation area will decrease the valid detection probability. 
3. Maximum in-plane displacement should be less than ¼ of the interrogation spot. 
This will minimize loss of particle pairs, making more particle pairs available for 
correlation, which increases correlation peak strength. 
4. Maximum out of plane displacement should be less than ¼ of laser light sheet 
thickness. This will minimize out of plane particle loss. 
5. Minimum in-plane displacement should be two particle-image diameters. This 
rule ensures that a particle pair is identified as two distinct images of the same 
particle as opposed to one elliptical particle image. 
6. The exposure must be large enough to clearly show particles. 
During the image acquisition process of this experimentation, compliance of the preceding rules 
was maintained.  This, in addition to other specifics including the frame straddling technique and 
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utilization of the Insight software, ensured accurate and repeatable fluid flow representation 
through effective image acquisition and vector plot processing. 
3.3.2.1 Frame Straddling 
The frame transfer period associated with the 30 Hz CCD camera frame rate limits the 
minimum time separation between lasers. Hence, high velocity flow analysis is impractical [37]. 
However this experimentation employs frame straddling to increase the effective frame rate of 
the PIV hardware. The frame straddling technique uses a synchronized timing function to pulsate 
the laser at the end of the first camera exposure and again at the beginning of the subsequent 
exposure. This controlled timing permits the measurement of high velocity fluid flow by 
shortening the time interval between laser pulses [37].  The timing diagram for frame straddling 
is shown in Figure 3.13. 
 
Figure 3.13. [37] Frame Straddling. 
 
As previously stated, the utilized CCD camera has a fixed rate for frame acquisition but the time 
interval between any two images is adjustable, which allows for accurate representation of the 
flow field. 
56 
 
3.3.2.2 Interrogation Area Size 
In addition to laser pulse time interval tuning, the size of the interrogation area is another 
major determining factor in image acquisition and processing. Interrogation area size was chosen 
to minimize noise and increase accuracy. Spatial resolution increases as the interrogation area 
size decreases; however, lowering the interrogation area size is more conducive to low velocity 
measurements because higher velocities produce more in-plane particle loss [37]. The 1008 x 
1018 square pixels CCD camera provides significant precision to the detail seen in a particular 
region of interest. The typical size of an interrogation area, as stated by the TSI PIV owner 
manual, is 32 x 32 pixels [37]. The Insight software offers the user the ability to mask regions 
within the interrogation area so as to ignore user specified regions during post processing. Once 
the mask regions are selected the software continues the examination of the remaining unmasked 
interrogation areas of the paired frames. During processing of these unmasked areas, each 
particle image is identified and matched to the corresponding image of the same particle across a 
pair of frames. After identification, their respective locations are computed and compared to one 
another using an internal correlation function. The size of the pixel array of the interrogation area 
can be modified using the software, which will change the number of velocity vectors to be 
calculated. 
3.3.2.3 Software 
The PIV system utilizes the Insight software to analyze and display velocity vector plots. 
The software divides and processes digital images of designated interrogation areas within the 
flow field. Insight determines the number of usable particles and their corresponding locations 
within the paired frames. These corresponding particle images, within the designated 
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interrogation areas, are compared via a correlation function that identifies the most common 
displacement in a given time interval and displays it as a velocity vector. Velocity vectors are 
shown as graphic overlays across the initial image capture and consist of magnitude and 
direction information.  The Insight software provides several cross correlation algorithm options 
to choose from during analysis including Fast Fourier Transforms (FFT). This experiment 
utilizes the HART correlation algorithm that was developed at Massachusetts Institute of 
Technology [33]. HART correlation presents the ability to compress data and use intensity 
information more efficiently [33]. It produces four times the number of vectors compared to the 
frequently used FFT, which enables the system to visualize more detailed fluid flow information 
[33]. 
In order to optimize the image capture process, it is critical to select the proper ∆t value. 
The ∆t is the time interval between the independently pulsed laser pulses. ∆t selection can be 
done manually or via an internal process conducted by the Insight software that estimates an 
optimum ∆t value. In this experiment a ∆t value of 300 µs was used with 25 ms pulse separation. 
Additionally, post-processing by the Insight software includes the ability to remove flawed 
vectors using a variety of different filters such as mean, median, standard deviation, and 
smoothing [33]. Utilization of TecPlot, provides the ability to compute speed, vorticity, velocity 
gradients, and flow contours [33]. 
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4   RESULTS 
 
 The ensuing sections present data acquired by the mock loop pressure transducers and 
flow meter. This information was displayed, in real-time, on the CPU Dashboard and collected 
and stored in an Excel file. A total of twelve different heart rate and stroke volume combinations 
were set with corresponding resistances to maintain a peak systolic pressure in the range of 110 
to 140 mmHg. This peak systolic pressure was measured by the pressure transducer embedded 
within the compliance chamber. The twelve examined combinations are listed in Table 4.1 along 
with their corresponding resistor positions. In addition, for each data set a sequence of 20 images 
was taken by the PIV system at the MHV test chamber location using a 28mm lens. Only images 
from one complete tilting disk valve opening cycle is displayed for each setup. The CCD camera 
was operated at a 30 Hz frame rate, which denotes a 33.33 ms time between image captures. 
Pressure and flow data are displayed for the time scale ranging from 0 to 3 seconds. 
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Heart Rate (BPM) Stroke Volume (mL) Resistor Position 
60 70 330 
70 70 325 
80 70 325 
90 70 320 
70 50 330 
70 60 330 
70 80 320 
70 90 315 
90 55 325 
60 60 340 
80 80 315 
95 80 305 
Table 4.1. Experimental heart rate and stroke volume combinations with corresponding resistor position. 
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4.1 60 BPM at 70mL Stroke Volume 
 
 
 
Figure 4.1a. PIV images of one complete 
tilting disk valve opening cycle for 60 BPM 
with 70mL SV. 
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Figure 4.1b. Pressure (top) and flow (bottom) data for 60 BPM with 70mL SV. 
 
The data in Figure 4.1a and 4.1b was acquired while the Harvard pump was set to 
operate at 60 BPM with a 70mL SV. At this HR, the tilting disk valve successfully completes 60 
opening cycles per minute. The Harvard pumping cycle is represented by one full phase in each 
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of the displayed waves, pressure and flow. The pumping cycle takes 1 second with an average 
aortic peak systolic pressure at 116.33 mmHg and average minimum diastolic pressure of 39.00 
mmHg. These values were measured by the pressure transducer just before entering the 
compliance chamber (99G99F22-X14), which indicates the natural aortic location. 
Measurements inside the compliance chamber indicate a mean mock loop system pressure of 
137.33/62.33 mmHg. The tilting disk valve opens 0.1 seconds after the minimum diastolic 
pressure occurs and closes 0.15 seconds after peak systolic pressure. The tilting disk valve is 
open 0.33 seconds of the pumping cycle. Valve closure is represented by the formulated “dicrotic 
notch” on the blue pressure wave above, which marks the end of the systolic period. The dicrotic 
notch is signified by the small downward deflection of the blue pressure wave that occurs at t = 
0.45, 1.35, and 2.20 seconds. This small fluctuation in the downward slope of the pressure phase 
is created by the rebound action of the tilting disk valve, which correlates with the negative flow 
values seen at t = 0.45, 1.45, and 2.45 seconds on the flow wave. The flow meter measured an 
average high instantaneous flow rate of 11.20 L per minute during the opening of the tilting disk 
valve. The cardiac output of the mock loop at these conditions was 4.2 L per minute. 
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4.2 70 BPM at 70mL Stroke Volume 
 
 
Figure 4.2a. PIV images of one complete tilting disk valve opening cycle for 
70 BPM with 70mL SV. 
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Figure 4.2a and 4.2b displays data when the Harvard pump operated at 70 BPM with a 
70mL SV. At this HR, the tilting disk valve successfully opens 70 times per minute. The 
pumping cycle takes 0.86 seconds with an average aortic peak systolic pressure at 119.33 mmHg 
 
 
 
Figure 4.2b. Pressure (top) and flow (bottom) data for 70 BPM with 70mL SV. 
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and average minimum diastolic pressure of 44.00 mmHg measured by pressure transducer 
99G99F22-X14. Measurements inside the compliance chamber indicate a mean mock loop 
system pressure of 140.00/66.33 mmHg. The tilting disk valve opens 0.09 seconds after the 
minimum diastolic pressure occurs and closes 0.13 seconds after peak systolic pressure. The 
tilting disk valve is open 0.30 seconds of the pumping cycle. The dicrotic notch occurs at t = 
0.43, 1.29, 2.15, and 3.00 and correlates with negative flow values seen at identical times on the 
flow wave. The flow meter measured an average high instantaneous flow rate of 13.375 L per 
minute during the opening of the tilting disk valve. The cardiac output of the mock loop at these 
conditions was 4.9 L per minute. 
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4.3 80 BPM at 70mL Stroke Volume 
 
 
Figure 4.3a. PIV images of one complete tilting disk 
valve opening cycle for 80 BPM with 70mL SV. 
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Figure 4.3b. Pressure (top) and flow (bottom) data for 80 BPM with 70mL SV. 
 
Figure 4.3a and 4.3b above shows information gathered from the Harvard pump 
operated at 80 BPM with a 70mL SV. This HR and SV combination produces a cardiac output of 
5.6 L per minute in the mock loop. The pumping cycle has an average aortic peak systolic 
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pressure at 119.33 mmHg, average minimum diastolic pressure of 44.00 mmHg, and a total 
duration of 0.75 seconds with these pressure values measured by pressure transducer 99G99F22-
X14. The tilting disk valve opens 80 times per minute. The pressure transducer inside the 
compliance chamber monitors a mean mock loop system pressure of 135.67/65.00 mmHg. The 
tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 0.12 
seconds after peak systolic pressure. The tilting disk valve is open 0.23 seconds of the pumping 
cycle. The dicrotic notch occurs at t = 0.35, 1.10, 1.85, and 2.60 seconds and correlates with 
negative flow values seen at identical times on the flow wave. The flow meter measured an 
average high instantaneous flow rate of 15.90 L per minute during the opening of the tilting disk 
valve. 
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4.4 90 BPM at 70mL Stroke Volume 
 
 
Figure 4.4a. PIV images of one complete tilting disk 
valve opening cycle for 90 BPM with 70mL SV. 
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Figure 4.4a. Pressure data (top) and flow (bottom) data for 90 BPM with 70mL SV. 
 
Data illustrated in Figure 4.4a and 4.4b is representative of a 90 BPM, 70mL SV 
Harvard pump operation. The tilting disk valve completes 90 opening cycles per minute during a 
0.67 second pumping cycle interval.  The average aortic peak systolic pressure and average 
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minimum diastolic pressure were 102.00 mmHg and 41.50 mmHg, respectively, measured by the 
99G99F22-X14 pressure transducer. Measurements inside the compliance chamber indicate a 
mean mock loop system pressure of 120.40/52.00 mmHg. The dicrotic notch occurs at the 
instance of negative flow on the flow wave at t = 0.33, 1.00, 1.67, 2.34, and 3.00. The opening of 
the tilting disk valve produces a mock loop average high instantaneous flow rate of 17.02 L per 
minute. The tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and 
closes 0.12 seconds after peak systolic pressure. One tilting disk opening sequence inhabits 0.22 
seconds of the total pumping cycle time. The cardiac output of the mock loop at these conditions 
was 6.3 L per minute. 
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4.5 70 BPM at 50mL Stroke Volume 
 
 
Figure 4.5a. PIV images of one complete tilting disk valve opening cycle for 70 
BPM with 50mL SV. 
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Figure 4.5b. Pressure (top) data and flow (bottom) data for 70 BPM with 50mL SV. 
 
Figure 4.5a and 4.5b above shows information gathered from the Harvard pump 
operated at 70 BPM with a 50mL SV. This HR and SV combination produces a cardiac output of 
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3.5 L per minute in the mock loop. The pumping cycle has an average aortic peak systolic 
pressure at 96.25 mmHg, average minimum diastolic pressure of 29.67 mmHg, and a total 
duration of 0.86 seconds with these pressure values measured by pressure transducer 99G99F22-
X14. The tilting disk valve cycles 70 times per minute. The pressure transducer inside the 
compliance chamber monitors a mean mock loop system pressure of 117.50/61.00 mmHg. The 
tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 0.13 
seconds after peak systolic pressure. The tilting disk valve is open 0.30 seconds of the pumping 
cycle. The dicrotic notch occurs at t = 0.41, 1.27, 2.13, and 2.99 seconds and correlates with 
negative flow values seen at identical times on the flow wave. The flow meter measured an 
average high instantaneous flow rate of 9.625 L per minute during the opening of the tilting disk 
valve. 
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4.6 70 BPM at 60mL Stroke Volume 
 
 
Figure 4.6a. PIV images of one complete tilting disk valve opening cycle for 70 BPM 
with 60mL SV. 
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Figure 4.6b. Pressure (top) data and flow (bottom) data for 70 BPM with 60mL SV. 
 
Figure 4.6a and 4.6b displays data when the Harvard pump operated at 70 BPM with a 
60mL SV. At this HR, the tilting disk valve successfully opens 70 times per minute. The 
pumping cycle takes 0.86 seconds with an average aortic peak systolic pressure at 116.50 mmHg 
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and average minimum diastolic pressure of 47.67 mmHg measured by pressure transducer 
99G99F22-X14. Measurements inside the compliance chamber indicate a mean mock loop 
system pressure of 139.25/76.00 mmHg. The tilting disk valve opens 0.09 seconds after the 
minimum diastolic pressure occurs and closes 0.13 seconds after peak systolic pressure. The 
tilting disk valve is open 0.30 seconds of the pumping cycle. The dicrotic notch occurs at t = 
0.43, 1.29, 2.15, and 3.00 and correlates with negative flow values seen at identical times on the 
flow wave. The flow meter measured an average high instantaneous flow rate of 11.275 L per 
minute during the opening of the tilting disk valve. The cardiac output of the mock loop at these 
conditions was 4.2 L per minute. 
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4.7 70 BPM at 80mL Stroke Volume 
 
 
Figure 4.7a. PIV images of one complete tilting disk valve opening cycle for 70 BPM 
with 80mL SV. 
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Figure 4.7b. Pressure (top) data and flow (bottom) data for 70 BPM with 80mL SV. 
 
Graphs in Figure 4.7a and 4.7b are representative of a 70 BPM, 80mL SV Harvard pump 
operation. The tilting disk valve completes 70 opening cycles per minute during a 0.86 second 
pumping cycle interval. It opens 0.1 seconds after the minimum diastolic pressure occurs and 
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closes 0.13 seconds after peak systolic pressure. One tilting disk opening sequence inhabits 0.30 
seconds of the total pumping cycle time. The average aortic peak systolic pressure and average 
minimum diastolic pressure were 103.00 mmHg and 30.00 mmHg, respectively, measured by the 
99G99F22-X14 pressure transducer. Measurements inside the compliance chamber indicate a 
mean mock loop system pressure of 124.00/49.33 mmHg. The dicrotic notch occurs at the 
instance of negative flow on the flow wave at t = 0.25, 1.11, 1.91, and 2.77. The opening of the 
tilting disk valve produces a mock loop average high instantaneous flow rate of 17.00 L per 
minute. The cardiac output of the mock loop at these conditions was 5.6 L per minute. 
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4.8 70 BPM at 90mL Stroke Volume 
 
Figure 4.8a. PIV images of one complete tilting disk valve opening cycle for 70 BPM 
with 90mL SV. 
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Figure 4.8b. Pressure data (top) and flow (bottom) data for 70 BPM with 90mL SV. 
 
Figure 4.8a and 4.8b above shows information gathered from the Harvard pump 
operated at 70 BPM with a 90mL SV. It creates a cardiac output of 6.3 L per minute in the mock 
loop. The pumping cycle has an average aortic peak systolic pressure at 93.50 mmHg, average 
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minimum diastolic pressure of 18.00 mmHg, and a total duration of 0.86 seconds with these 
pressure values measured by pressure transducer 99G99F22-X14. The pressure transducer inside 
the compliance chamber monitors a mean mock loop system pressure of 117.50/35.33 mmHg. 
The tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 
0.12 seconds after peak systolic pressure. It opens 70 times per minute during a 0.30 second 
pumping cycle. The dicrotic notch occurs at t = 0.40, 1.26, 2.12, and 2.98 seconds and correlates 
with negative flow values seen at identical times on the flow wave. The flow meter measured an 
average high instantaneous flow rate of 18.45 L per minute, which denotes the opening of the 
tilting disk valve. 
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4.9 90 BPM at 55mL Stroke Volume 
 
 
Figure 4.9a. PIV images of one complete tilting disk valve opening cycle for 90 BPM 
with 55mL SV. 
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Figure 4.9b. Pressure (top) data and flow (bottom) data for 90 BPM with 55mL SV. 
 
A cardiac output of 4.95 L per minute was created in the mock loop by running the 
Harvard pump at 90 BPM with a 55mL SV. Figure 4.9a and 4.9b above shows the acquired 
data. The average aortic peak systolic pressure of the pumping cycle is 98.60 mmHg and average 
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minimum diastolic pressure was 38.25 mmHg measured by pressure transducer 99G99F22-X14 
at the mock loop aortic location. One pumping cycle lasted 0.67 seconds and contains one valve 
opening phase; the tilting disk valve opens 90 times per minute under these conditions. The valve 
opens for 0.22 seconds during the pumping cycle where initiation occurs 0.1 seconds after the 
minimum diastolic pressure and closure 0.13 seconds after peak systolic pressure. The pressure 
transducer inside the compliance chamber registers a mean mock loop system pressure of 
118.40/62.25 mmHg. The dicrotic notch and negative flow regions occur at t = 0.31, 0.98, 1.65, 
2.32, and 2.99 seconds. The flow meter measured an average high instantaneous flow rate of 
15.55 L per minute during the opening of the tilting disk valve. 
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4.10 60 BPM at 60mL Stroke Volume 
 
 
Figure 4.10a. PIV images of one complete 
tilting disk valve opening cycle for 60 BPM 
with 60mL SV. 
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Figure 4.10b. Pressure (top) and flow (bottom) data for 60 BPM with 60mL SV. 
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The data in Figure 4.10a and 4.10b was acquired while the Harvard pump was set to 
operate at 60 BPM with a 60mL SV. At this HR, the tilting disk valve completed 60 opening 
cycles per minute. The Harvard pumping cycle takes 1 second with an average aortic peak 
systolic pressure at 116.00 mmHg and average minimum diastolic pressure of 40.00 mmHg 
measured by the pressure transducer just before entering the compliance chamber (99G99F22-
X14). Measurements inside the compliance chamber indicate a mean mock loop system pressure 
of 132.00/66.67 mmHg. The tilting disk valve opens 0.1 seconds after the minimum diastolic 
pressure occurs and closes 0.14 seconds after peak systolic pressure. The tilting disk valve is 
open 0.33 seconds of the pumping cycle. Small downward deflection of the blue pressure wave 
(dicrotic notch) at t = 0.45, 1.45, and 2.45 correlate with the negative flow values on the flow 
wave. The flow meter measured an average high instantaneous flow rate of 9.47 L per minute 
during the opening of the tilting disk valve. The cardiac output of the mock loop at these 
conditions was 3.6 L per minute. 
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4.11 80 BPM at 80mL Stroke Volume 
 
 
Figure 4.11a. PIV images of one complete tilting 
disk valve opening cycle for 80 BPM with 80mL SV. 
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Figure 4.11b. Pressure (top) and flow (bottom) data for 80 BPM with 80mL SV. 
 
Figure 4.11a and 4.11b above shows information gathered from the Harvard pump 
operated at 80 BPM with a 80mL SV. This HR and SV combination produces a cardiac output of 
6.4 L per minute in the mock loop. The pumping cycle has an average aortic peak systolic 
pressure at 101.50 mmHg, average minimum diastolic pressure of 33.25 mmHg, and a total 
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duration of 0.75 seconds with these pressure values measured by pressure transducer 99G99F22-
X14. The tilting disk valve opens 80 times per minute. The pressure transducer inside the 
compliance chamber monitors a mean mock loop system pressure of 120.00/44.25 mmHg. The 
tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 0.12 
seconds after peak systolic pressure. The tilting disk valve is open 0.23 seconds of the pumping 
cycle. The dicrotic notch occurs at t = 0.30, 1.05, 1.82, and 2.60 seconds and correlates with 
negative flow values seen at identical times on the flow wave. The flow meter measured an 
average high instantaneous flow rate of 17.675 L per minute during the opening of the tilting 
disk valve. 
93 
 
4.12 95 BPM at 80mL Stroke Volume 
 
 
Figure 4.12a. PIV images of one complete tilting 
disk valve opening cycle for 95 BPM with 80mL 
SV. 
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Figure 4.12b. Pressure (top) and flow (bottom) data for 95 BPM with 80mL SV. 
 
Illustrations in Figure 4.12a and 4.12b present data for a 95 BPM, 80mL SV Harvard 
pump operation. The tilting disk valve completes 95 opening cycles per minute during a 0.63 
second pumping cycle interval.  The average aortic peak systolic pressure and average minimum 
diastolic pressure were 99.80 mmHg and 32.25 mmHg, respectively, measured by the 
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99G99F22-X14 pressure transducer. Measurements inside the compliance chamber indicate a 
mean mock loop system pressure of 118.20/38.00 mmHg. The dicrotic notch occurs at the 
instance of negative flow on the flow wave at t = 0.38, 1.01, 1.72, and 2.35. The opening of the 
tilting disk valve produces a mock loop average high instantaneous flow rate of 22.14 L per 
minute. The tilting disk valve opens 0.12 seconds after the minimum diastolic pressure occurs 
and closes 0.15 seconds after peak systolic pressure. One tilting disk opening sequence inhabits 
0.21 seconds of the total pumping cycle time. The cardiac output of the mock loop at these 
conditions was 7.6 L per minute. 
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4.13 Vector Plots 
In order to provide evidence of the ability to obtain vector plot data using this system, 
one set of PIV images were post-processed. Figure 4.13a through 4.13i show vector information 
downstream of the experimental tilting disk valve at 60 BPM with 60mL SV. Unlike the 
previous results, these images were captured orthogonal to the fluid flow region using a 50 mm 
lens, which provides a more localized imaging area. In these vector plots, positive fluid flow is 
indicated by right pointing arrows and the tilting disk valve is located to the left of the vector 
plot. 
 
Figure 4.13a. Vector plot for 60 BPM with 60mL SV. End of systolic phase, just before valve closure. 
Entering pump drawback. 
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Figure 4.13a represents flow at the end of the pump systolic phase and just before the valve 
closes. The majority of the shown vectors are oriented in the reverse direction. This indicates that 
the pump is entering drawback and there is negative fluid flow. Several regions present a 
swirling, turbulent flow area within the flow as the fluid flow transfers from predominantly 
positive, forward movement to negative, backflow. 
 
 
Figure 4.13b. Vector plot for 60 BPM with 60mL SV. Beginning of diastolic phase, just after valve 
closure, start of pump drawback. 
Figure 4.13b represents flow at the beginning of the pump diastolic phase and just after the 
valve closure. Most vectors are oriented in the reverse direction except those involved in areas of 
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turbulence. Pump drawback continues to induce negative fluid flow. Once again, several regions 
present a swirling, turbulent flow area within the flow; however, those regions are limited when 
compared to Figure 4.13a. 
 
 
Figure 4.13c. Vector plot for 60 BPM with 60mL SV. Diastolic phase, valve closed, middle of pump 
drawback. 
Figure 4.13c displays fluid flow during the pump diastolic phase. The test tilting disk valve has 
completely closed at this point. Pump drawback continues to induce negative fluid flow, which 
gives the vector an overall reverse current orientation. It shows a large stagnant region just 
downstream of the MHV location. 
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Figure 4.13d. Vector plot for 60 BPM with 60mL SV. Diastolic phase, valve closed, pump still in 
drawback. 
Figure 4.13d looks very similar to Figure 4.13c. In this figure fluid flow is presented during the 
pump diastolic phase. The test tilting disk valve is still completely closed and pump drawback 
causes negative fluid flow, as evidenced by the negative vector plot directions. The large 
stagnant region remains just downstream of the MHV location. 
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Figure 4.13e. Vector plot for 60 BPM with 60mL SV. Diastolic phase, valve closed, end pump drawback. 
Figure 4.13e displays fluid flow during the pump diastolic phase and at the end of pump 
drawback. The test tilting disk valve is completely closed and reverse fluid current is still 
evident. A stagnant flow region to the far left of the vector plot area is present. 
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Figure 4.13f. Vector plot for 60 BPM with 60mL SV. End of diastolic phase, just prior to valve opening. 
Figure 4.13f displays fluid flow at the end of the pump diastolic phase, just prior to opening of 
the tilting disk valve. The pump piston has begun its forward progression as it forces fluid out of 
the pump chamber; however, the effects have yet to show up in the vector plot. It still displays 
predominantly negative flow orientation but the stagnant flow region just downstream of the 
MHV location has reduced when compared to the previous figures. 
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Figure 4.13g. Vector plot for 60 BPM with 60mL SV. Start of systolic phase, just after valve opening. 
Figure 4.13g displays fluid flow at the start of the pump systolic phase. The test tilting disk 
valve has just opened and the vector plot reflects the positive fluid flow caused by the rush of 
fluid through the valve. It shows a large stagnant region just downstream of the MHV location. 
Several regions present a swirling, turbulent flow area as the fluid flow transfers from 
predominantly negative, backflow to positive, forward movement. 
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Figure 4.13h. Vector plot for 60 BPM with 60mL SV. Systolic phase, valve open. 
Figure 4.13h displays fluid flow during the pump systolic phase. The test tilting disk valve is 
open.  The vector plot shows several swirling, turbulent flow regions as fluid velocity increases 
through the MHV. The longer vectors indicate larger absolute velocity measurements. 
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Figure 4.13i. Vector plot for 60 BPM with 60mL SV. Peak systolic phase, valve completely open. 
Figure 4.13i presents fluid flow at peak pump systole when the test tilting disk valve is 
completely open.  The vector plot continues to display several swirling, turbulent flow regions as 
fluid velocity is at its maximum. 
105 
 
5 DISCUSSION, CONCLUSION, AND LIMITATIONS 
 
5.1 Discussion 
This experiment included 12 different conditional setups with 20 images captured for 
each at the MHV test chamber location in the automated mock circulatory loop in the Artificial 
Heart Laboratory at Virginia Commonwealth University. The images are captured in sequence, 
33.33 ms apart, and depicted the operation of an experimental tilting disk valve for the following 
combinations of HR-SV parameters: 1. 60BPM-70mL, 2. 70BPM-70mL, 3. 80BPM-70mL, 4. 
90BPM-70mL, 5. 70BPM-50mL, 6. 70BPM-60mL, 7. 70BPM-80mL, 8. 70BPM-90mL, 9. 
90BPM-55mL, 10. 60BPM-60mL, 11. 80BPM-80mL, and 12. 95BPM-80mL. One tilting disk 
valve opening cycle was presented for each experimental condition set. The systolic to diastolic 
phase ratio was 50% for all setups and the mock loop peripheral resistor was altered for each in 
order to maintain a peak systolic pressure in the mock loop compliance chamber within the range 
of 110 to 140 mmHg. This experiment helps to determine the effectiveness of a completely 
automated mock circulatory loop and a novel test chamber in the evaluation of MHVs. It 
primarily focuses on the ability to gather relative fluid dynamic data, at the MHV location, while 
providing the capability to quickly interchange MHV types and set various physiological 
conditions. Thus, the objective was to improve upon the efficiency of current MHV in vitro test 
methods by developing a system that requires less time to manipulate loop parameters and 
components while maintaining current MHV testing loop and chamber standards. 
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5.1.1 Mock Circulatory Loop Performance 
Evaluation of the experimental mock circulatory loop system for MHV performance 
testing consisted of satisfaction of two primary criterion: 1. the system’s capacity to produce 
pressure waves similar to those shown in a typical Wiggers diagram, and 2. the system’s ability 
to expose the test MHV at a wide range of mimicked physiological conditions.  
5.1.1.1 Wiggers Diagram Comparison 
The observed shapes of the collected mock loop pressure waveforms effectively compare 
to the theoretical cardiac Wiggers diagram. As shown in Figure 5.1, the three major regions of 
the aortic pressure response, denoted by the theoretical Wiggers diagram, were successfully 
exhibited by the experimental mock loop system. The labeled regions designate the following 
occurrences within the native heart cycle. 
a. represents the opening of the aortic valve and the beginning of left ventricular systole 
b. represents the peak systolic pressure 
c. represents the closing of the aortic valve and the end of left ventricular systole 
Furthermore, Figure 5.2 shows the left ventricular pressure response, which also indicates a high 
correlation between the Wiggers diagram and the experimental mock loop pressure waveform. 
Presence of the labeled regions in Figure 5.2 indicates the following. 
d. represents closure of the mitral valve and the end of left ventricular diastole 
e. represents the opening of the mitral valve and the beginning of left ventricular 
diastole 
The generation of the aforementioned regions by the experimental mock loop confirms its ability 
to adequately duplicate the events of the native left ventricle heart cycle. 
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Figure 5.1. Aortic pressure waveform shape comparison to theoretical Wiggers diagram. 
 
Figure 5.2. Left ventricular pressure waveform shape comparison to theoretical Wiggers diagram. 
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Figure 5.3 illustrates the typical pressure range (mmHg) presented by the Wiggers 
diagram as compared to the pressure range (mmHg) created by the experimental mock loop at 60 
BPM and 60 mL SV. The Wiggers diagram has an effective left ventricular pressure range of 
120 mmHg and an effective aortic pressure range of 40 mmHg. In addition, both Wiggers 
diagram pressure waveforms peak at approximately 120 mmHg. For the experimental mock 
loop, the effective left ventricular pressure range is approximately 65 mmHg and the effective 
aortic pressure range is approximately 50 mmHg. In addition, the difference between the peak 
systolic pressure of the aortic pressure replication and the left ventricular pressure representation 
is approximately 15 mmHg. This loss of energy can be attributed to the drawback nature of the 
pump which lowers the pressure values considerably. Since the test MHV is located closer to the 
pump than the compliance chamber, the pumps negative pressure has a much greater effect on 
the aortic pressure replication data than on the left ventricular pressure representation data. In 
sense, the MHV shields the compliance chamber pressure from being dragged down as the 
pulsatile pump enters diastole. This pump drawback is explained in more detail in the 
“Experimental Errors and Limitations” section. 
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Figure 5.3. Pressure waveform range comparison to theoretical Wiggers diagram. 
 
5.1.1.2 Physiological Simulation Range 
The experimental mock loop was able to effectively mimic a wide range of physiological 
pathologies via manipulation of fluid dynamics. The Harvard pulsatile pump was able to produce 
a number of HR-SV combinations with HR ranging from 0 to 95 BPM and SV ranging from 15 
to 100 mL. Increasing or decreasing one or both HR or SV alters the system cardiac output 
which simulates conditions including rest, normal, exercise, and failing heart scenarios. This 
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allows for the observation of MHV performance through the measurement of fluid dynamic 
information such as pressure and flow rate. Validation of HR and SV settings was completed via 
analysis of pressure and flow data waveforms. HR was checked for accuracy by pressure and 
flow wave frequency calculation and SV was confirmed by integration under the flow wave. The 
scope of the Harvard pump in conjunction with capacitance and resistance manipulation 
presented the ability to effectively imitate the native’s heart capacity to operate in various 
pathologies. Furthermore, the transformation from manual control to digital control of these 
components, with feedback assessment, allowed for relatively instantaneous interchangeability 
between the mimicked physiological conditions. 
5.1.2 Pressure and Flow Data 
 Pressure measurements throughout experimentation provided feedback for the monitoring 
of aortic pressure just after the tilting disk valve in the mock loop. Each of the acquired pressure 
waveforms effectively mimic the aortic pressure waveforms created by the native heart. These 
waveforms include a rapid increase in pressure up to the peak systolic pressure and a slower 
decline to minimum diastolic pressure. Observation of the aortic pressure waveform also shows 
the opening of the tilting disk valve during the rapid increase phase and closure during the slow 
decline phase. Both the opening and closure are denoted by sudden pressure value fluctuations in 
the relatively smooth wave. At the onset of valve opening, aortic pressure drops suddenly due to 
the increase in volume area because the valve no longer provides resistance to the fluid. This 
pressure drop is fairly small in time because the abrupt rush of fluid into the aorta causes the 
aortic pressure to once again rise until it reaches the peak systolic pressure. Similarly, a sudden 
rise in pressure occurs during the slow fall of aortic pressure as the valve closes. This pressure 
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fluctuation is more commonly known as the dicrotic notch. The dicrotic notch occurs when the 
valve closes and restricts fluid flow, thus, momentarily trapping a high volume of fluid in the 
aorta. Almost instantaneously the aorta constricts and forces the fluid through the circulatory 
system, which once again causes the aortic pressure to fall. These changes form a small 
“sawtooth” indentation in the pressure waveform. Location of the dicrotic notch is a major 
notification in the diagnosis of several pathologies such as hypovolemia. Therefore, the dicrotic 
notch is a good indication of valve functionality and its consequent effects on fluid flow. Valve 
closure is also indicative of flow stagnation, which is linked to thrombotic activity. Furthermore, 
manipulation of the peak systolic pressure by capacitance and resistance variability presents the 
ability to expose test MHVs to different mechanical conditions, which is important during 
durability and mechanical failure testing. The system also created a fairly low diastolic pressure 
for all condition experiments, which will be further discussed in the errors and limitations 
section. 
 In addition to pressure data, flow data is extremely important in MHV performance 
evaluation. The instantaneous detection of fluid flow just after the valve provides information for 
the effects of valve design on fluid dynamics. Negative flow regions on the flow waveform 
suggests periods of backflow during circulation, especially at the test MHV location. Backflow 
plays a role in valve closure and is a means of washing thrombus deposition from the valve. It is 
created when filling of the pump during the diastolic phase presents a low pressure in the pump 
while the pressure in the aortic section remains high. This pressure gradient forces flow to move 
from the region of high pressure towards the region of low pressure in order to stabilize the 
system. Low aortic pressures present little to no backflow; however, high aortic pressures cause 
the magnitude of fluid backflow to rise. Thus, in the instance of a faulty valve and high aortic 
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pressure, backflow will negatively affect cardiac output. Additionally, backflow also leads to 
flow recirculation or swirling. So if MHV design creates a high shear stress region and the blood 
flows back through that region during backflow it raises the exposure time of the red blood cells 
to high shear stress which raises the potential for hemolytic activity. MHVs that present high 
potentials for thrombosis and/or hemolysis are not ideal for implantation, which enhances the 
significance of in vitro testing and measurement of fluid flow. Therefore, the instantaneous flow 
measurement and ability to quickly change physiological conditions become increasingly more 
important. 
5.1.3 PIV Imaging 
 For the purpose of this research, images acquired by the PIV system were used to validate 
proper valve mechanical functionality and particle illumination for post-processing. Particle 
illumination is a key element in computing fluid flow profiles. These profiles, usually vector 
and/or contour plots, provide local velocity information for a designated flow field. Therefore, 
they relay qualitative and quantitative visualization data relevant to stagnant and swirling 
backflow regions that may promote thrombotic and/or hemolytic activity. In this 
experimentation, imaging at the test valve site in the mock loop showed adequate particle 
illumination and thus, with further processing, will provide local velocity data of fluid flow 
exiting the valve. This will allow in vitro prediction of native fluid dynamics for a particular 
valve design. In order to establish proof of concept for this imaging data, vector plot post-
processing was completed for only one parameter set, 60 BPM at 60mL SV. 
Furthermore, synchronization of the image acquisition process with the mock loop 
measuring instruments enabled flow field interpretations to be developed from the computed 
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pressure and flow waveforms. This was completed via the implementation of a time-stamp, 
generated TTL signal that initiated the PIV imaging process. As previously noted, negative 
measurements on the flow waveform indicate reversal of fluid flow, backflow. These negative 
flow time periods begin just before the valve closes, as the last couple of images in each set of 
tilting disk valve opening cycle illustrations. Furthermore, negative flow recordings coincide 
with the Harvard pump’s diastolic phase in which its function is dominated by the motor 
drawback mechanics. Pump diastole ensues throughout valve closure. The combination of these 
phenomena implies regurgitant or swirling flow at the tilting disk valve location during its 
closing phase. Integration of the negative flow region provided quantitative data with respect to 
the amount of backflow observed during each set of operating conditions. From this data, it was 
observed that regurgitant volume increased with SV increase and decreased with HR escalation. 
These regurgitant volume responses can be attributed to direct relationships to total volume 
discharged by the pump, SV, and total time spent in diastolic phase, HR. Total backflow volume 
is proportional to SV, so a change in one represents a similar change in the other, when all other 
loop parameters are held constant. In contrast, total backflow volume is indirectly related to the 
amount of time that the valve is exposed to the diastolic phase of the pump. Therefore, as HR 
increases, the pump diastolic phase duration is lowered and less backflow occurs. The highest 
amount of backflow was seen at 60 BPM and 70mL SV, while the least was at 90 BPM and 
55mL SV. Indicating that HR had a greater effect on regurgitant volume than SV in the 
investigated mock loop system. Lastly, all acquired images showed the tilting disk valve opening 
to a 60 degree tilt that produced a major and minor flow region. 
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5.2 Experimental Errors and Limitations 
 A consistent, uniform experimental setup is always ideal in research. However, 
procedural errors and/or limitations will continually present the opportunity for deviation away 
from the ideal scenario. During this experimentation, most faults were attributed to the Harvard 
pulsatile pump with the biggest setback occurring in the diastolic phase of the pumping cycle. 
Unlike the natural positive pressure filling ventricle, the Harvard pulsatile pump in this research 
creates a negative pressure head, up to -90 mmHg, during its filling phase. This large negative 
pressure creates a larger transvalvular pressure gradient across the test valve, when compared to 
observed native behavior, because it pulls down the pressure in the section of the mock just 
before the valve. The enhanced pressure differential on each side of the valve causes an 
increased backflow response as the fluid rapidly attempts to move from the high pressure aortic 
region back through the valve, in the reverse direction, towards the lower pressure area on the 
other side. So as the valve prepares to close, a larger than normal amount of fluid regurgitates 
back through the valve prior to shutting. The pump’s negative pressure phenomenon drags the 
diastolic pressure in the system down to a lower than expected value and also slightly raises the 
systolic pressure. It also lowers the anticipated cardiac output value. For example, running the 
pump at 60 BPM with a 60mL SV produces a regurgitant value of approximately 25mL per 
stroke, which creates a cardiac output of 2.1 L/min. This is a 1.5 L/min reduction from the 
expected 3.6 L/min cardiac output, which is about a 40% deviation. This creates major errors 
when attempting to evaluate valve performance during the diastolic phase and in relation to the 
amount of reverse flow generated by a particular valve design. 
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In addition to the error created by the problem above, another limitation is seen in the 
Harvard pump’s systolic to diastolic phase ratio. At the time of this experimentation, the pump 
was only able to operate in a 50% systolic to diastolic phase ratio setting because digital control 
had yet to be resolved for this aspect of pump functionality. The manual version of the Harvard 
pump was able to pulse with systolic/diastolic phase ratios ranging from 35 to 50%. Therefore, 
upon resolution of pump phase automation the pump will have similar limits. Native normal 
systolic/diastolic phase ratio is around 35 to 40%, which produces a slower pressure decent 
during the diastolic phase on a native normal ventricular pressure waveform, duplicated by the 
mock loop compliance chamber. In this experimentation, analysis of the pressure waveform 
within the compliance chamber shows a symmetrical wave phase. This is attributed to the equal 
amount of time spent in the systolic and diastolic phases during one pumping cycle. Therefore, 
the Harvard pulsatile pump will be able to provide a broader range of physiological pathologies 
when the initial manual systolic/diastolic phase ratio range is reestablished. 
 
5.3 Possible Future Progression 
The research location, Artificial Heart Laboratory at Virginia Commonwealth University, 
is in the process of making numerous other advancements in mock loop in vitro evaluation 
including improvements in aortic anatomical relevancy and adaptation of a second loop capacitor 
to simulate ventricular compliance. These improvements will further push the envelope of MHV 
in vitro independent and comparative testing by providing an advanced duplication of the native 
cardiovascular system. This assumption is based upon the notion that the ideal in vitro mock loop 
setup will perfectly simulate native physiology and provide the most reliable data. 
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5.4 Conclusion 
 With CHD being the leading cause of death in the United States and the number of global 
surgical heart valve procedures expected to exceed 850,000 annually by the year 2050 [4], heart 
valve treatment continues to major effects on the world’s population. In particular, patients who 
suffer from severe heart valve disorder and require replacement are in need of the development 
of an ideal valve replacement that provides longevity and minimal complications after 
implantation. MHVs are known to excel in durability concerns; however, questions of 
biocompatibility continue to warrant investigation into design improvements. The research 
presented here details the formulation of an in vitro process used to evaluate MHV functionality 
prior to patient implantation based upon fluid flow dynamics. The experimentation involves the 
design and manufacturing of a novel MHV test chamber in conjunction with an automated mock 
circulatory loop to improve upon the efficiency of other previous test setups. Emphasis was 
placed on the ability to reproduce a wide range of physiological pathologies as well as 
effectively image fluid flow and valve operation at the MHV test chamber location. Results 
presented positive feedback in reference to the mock loop’s ability to mimic the native 
cardiovascular system and the PIV system’s capacity to illuminate particles at the exit region of 
the test tilting disk heart valve, placed in the aortic valve position. A total of 12 HR-SV 
combinations were examined with all producing acceptable pressure and flow waveforms and 
image capture. Transformation from one set of parameters to another was relatively 
instantaneous and required minimal movement from the control computer site. Furthermore, 
proof of vector plot computation was presented. For these reasons, the researched novel MHV 
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test chamber, in conjunction with an automated mock loop, effectively functions as a test 
apparatus for MHV evaluation while improving upon the time and accuracy associated with 
alternate methods and systems. To increase accuracy in diastolic phase studies, the effects of the 
Harvard pump’s production of negative pressure during the diastolic phase should be further 
investigated and improved upon. 
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